
==== Front
Biogerontology
Biogerontology
Biogerontology
1389-5729
1573-6768
Springer Netherlands Dordrecht

38954358
10114
10.1007/s10522-024-10114-w
Review Article
Inhibitory immune checkpoints suppress the surveillance of senescent cells promoting their accumulation with aging and in age-related diseases
Salminen Antero antero.salminen@uef.fi

https://ror.org/00cyydd11 grid.9668.1 0000 0001 0726 2490 Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
1 7 2024
1 7 2024
2024
25 5 749773
19 4 2024
18 6 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The accumulation of pro-inflammatory senescent cells within tissues is a common hallmark of the aging process and many age-related diseases. This modification has been called the senescence-associated secretory phenotype (SASP) and observed in cultured cells and in cells isolated from aged tissues. Currently, there is a debate whether the accumulation of senescent cells within tissues should be attributed to increased generation of senescent cells or to a defect in their elimination from aging tissues. Emerging studies have revealed that senescent cells display an increased expression of several inhibitory immune checkpoint ligands, especially those of the programmed cell death protein-1 (PD-1) ligand-1 (PD-L1) proteins. It is known that the PD-L1 ligands, especially those of cancer cells, target the PD-1 receptor of cytotoxic CD8+ T and natural killer (NK) cells disturbing their functions, e.g., evoking a decline in their cytotoxic activity and promoting their exhaustion and even apoptosis. An increase in the level of the PD-L1 protein in senescent cells was able to suppress their immune surveillance and inhibit their elimination by cytotoxic CD8+ T and NK cells. Senescent cells are known to express ligands for several inhibitory immune checkpoint receptors, i.e., PD-1, LILRB4, NKG2A, TIM-3, and SIRPα receptors. Here, I will briefly describe those pathways and examine whether these inhibitory checkpoints could be involved in the immune evasion of senescent cells with aging and age-related diseases. It seems plausible that an enhanced inhibitory checkpoint signaling can prevent the elimination of senescent cells from tissues and thus promote the aging process.

Keywords

Ageing
Cellular senescence
Immunosenescence
Immunosuppression
Immunosurveillance
Inflammaging
University of Eastern Finland (including Kuopio University Hospital)Open access funding provided by University of Eastern Finland (including Kuopio University Hospital).

issue-copyright-statement© Springer Nature B.V. 2024
==== Body
pmcIntroduction

A chronic low-grade inflammation and immunosenescence are common immune-related hallmarks of the aging process; this remodelling phenomenon has been called inflammaging (Franceschi et al. 2018). While many age-related and chronic inflammatory diseases display similar properties, it does seem that these immune alterations are clearly augmented in these diseases. Nonetheless, the cellular state of senescence is a common feature encountered in both the aging process and many age-related diseases (Yanai and Fraifeld 2018; Mylonas and O'Loghlen 2022). Senescent cells are pro-inflammatory cells which secrete a number of inflammatory mediators, such as cytokines, chemokines, complements, and colony-stimulating factors (Rodier et al. 2009; Freund et al. 2010; Hernandez-Segura et al. 2018; Sikora et al. 2021). The pro-inflammatory phenotype has been called the senescence-associated secretory phenotype (SASP) (Campisi and Robert 2014). Currently, it seems that there are multiple causes to explain why cells will switch on the senescence phenotype which displays diverse pro-inflammatory properties in a context-dependent manner (Sikora et al. 2021; Wang et al. 2024a). For instance, the inducer of the senescent state and the cell type involved have a crucial role in the heterogeneity of the SASP (Wang et al. 2024a). Recently, several single-cell transcriptome studies have confirmed that many cell types isolated from aged tissues display a pro-inflammatory phenotype thus verifying results observed in cultured cells (Salzer et al. 2018; Benayoun et al. 2019; Zou et al. 2021; Xu et al. 2022). Moreover, the senescence in aged tissues has revealed the presence of a robust heterogeneity within cell populations. The single-cell transcriptomic studies also confirmed that an increased expression of senescence markers in isolated cells was associated with an enhanced expression of SASP factors. These studies verified that senescent cells are an important source of the elevated expression of pro-inflammatory factors in aged tissues.

The chronic inflammatory microenvironment, either associated with aging or as encountered in many inflammatory diseases, stimulates a counteracting immunosuppression in an attempt to maintain tissue homeostasis and thus avoid tissue destruction (Kanterman et al. 2012; Hotchkiss et al. 2013; Wang and DuBois 2015; Salminen 2020). There is abundant evidence that with aging the number of immunosuppressive cells was significantly increased in tissues. For instance, several investigators have revealed that the populations of regulatory T cells (Treg), myeloid-derived suppressor cells (MDSC), and M2 macrophages were augmented in aged tissues (Grizzle et al. 2007; Enioutina et al. 2011; Jackaman et al. 2013; Garg et al. 2014; Ruhland et al. 2016). The counteracting immune responses also involve the activation of inhibitory immune checkpoint pathways in many pathological states. The host tissues can inhibit the cytotoxic effects of CD8+ T and natural killer (NK) cells by increasing the expression of inhibitory checkpoint ligands which suppress the activity of these cytotoxic cells (Buckle and Guillerey 2021; Baldanzi 2022). Currently it is known that there are several inhibitory checkpoint receptor/ligand systems possessing different properties and distributions in many immune cells. The blockade therapies for certain inhibitory checkpoints are clinically used in cancer immunotherapy (Guo et al. 2023). Emerging studies have revealed that senescent cells can evade immune surveillance by activating the expression of the ligands for the programmed cell death protein 1 (PD-1) receptor, i.e., the PD-L1 protein on their cell surface (Onorati et al. 2022; Wang et al. 2022a; Salminen 2024). However, there are several other inhibitory checkpoint receptor/ligand systems which are associated with the immune surveillance of senescent cells. Here, I will briefly introduce those pathways which are known to control the immunosurveillance of senescent cells and examine whether they could be involved in the immune evasion of senescent cells associated with aging.

Accumulation of senescent cells increases with aging and in age-related diseases

Since the characterization of the major properties of senescent cells in cultured cells, there has been mounting interest to determine whether the same molecular markers could be upregulated in aging tissues. There is growing evidence indicating that the aging process is associated with a progressive increase in the expression of common markers of cellular senescence not only in the tissues of mammalian species (Krishnamurthy et al. 2004; Wang et al. 2009; Biran et al. 2017; Yanai and Fraifeld 2018; Idda et al. 2020; Yousefzadeh et al. 2020) but also in zebrafish, Caenorhabditis elegans, and Drosophila (Kishi 2004; Dmitrieva and Burg 2007; Ito and Igaki 2016). Moreover, single-cell transcriptome techniques have been used to confirm the presence of age-related senescence phenotypes in the cells of many murine tissues (Tabula Muris Consortium 2020; Zou et al. 2021). Several new techniques have recently become available to help to reveal in vivo the senescence process. For axample, there are now many reporter models that can monitor the gradual increase of senescence in aging mice (Gorgoulis et al. 2019; Gonzalez-Gualda et al. 2021). It seems that an age-related increase in senescence is a tissue-specific process which is greatly augmented in the mouse models of accelerated aging (Yousefzadeh et al. 2020; Cai et al. 2022). Interestingly, several mouse models of an accelerated aging have demonstrated that the removal of senescent cells from tissues actually attenuate pathological alterations taking place in aging tissues (Baker et al. 2016; Yi et al. 2023). For instance, Baker et al. (2011) developed a transgenic mouse model with an inducible elimination of the p16INK4a-positive cells, a common senescence marker (INK-ATTAC model). They demonstrated that both in wild-type and in the accelerated aging background (the BubR1 progeroid mouse) the depletion of senescent cells attenuated and delayed the appearance of many age-related pathologal changes. Currently there are many drug discovery programs aiming to develop pharmacological medications to eliminate senescent cells, i.e., senolytic therapies (Chaib et al. 2022; Zhang et al. 2023).

Many age-related diseases are associated with an expansion of cellular senescence although it seems that cellular senescence does not play the same role in different diseases. For example, it is known that cellular senescence can possess both tumor-suppressive and tumor-promoting properties in a phase-dependent manner (Sun et al. 2018; Takasugi et al. 2022). Given that senescent cells have pro-inflammatory properties, there is mounting evidence that cellular senescence acts as a driver of several age-related diseases, such as many cardiac diseases (Mehdizadeh et al. 2022), skin pathologies (Chin et al. 2023), atherosclerosis (Wu et al. 2020), and hepatic steatosis (Ogrodnik et al. 2017). The accumulation of fibrotic lesions is a significant pathological characteristic in certain age-related diseases. For example, there is clear evidence that cellular senescence, especially the senescence of stromal fibroblasts, enhanced the pathogenesis of fibrotic diseases, e.g., the clearance of senescent fibroblasts reduced the severity of fibrotic pulmonary lesions in mice (Schafer et al. 2017). Cellular senescence also has a crucial role in chronic kidney disease (Xu et al. 2020), myocardial fibrosis (Osorio et al. 2023), and systemic sclerosis (Tsou et al. 2022). It seems that cellular senescence may have a double-edge role in fibrotic diseases, i.e., it can either prevent or promote fibrosis, a feature also observed in tumor biology. Krizhanovsky et al. (2008) demonstrated that in murine hepatic liver fibrosis the presence of senescent hepatic stellate fibroblasts limited the progression of fibrosis and even facilitated the reversal of this pathological trait.

Currently, it is not known why senescent cells accumulate within tissues during aging and age-related diseases. Eventually, it could be attributable to an increase in the generation of senescent cells or to their reduced removal via impaired immune surveillance. There are diverse experimental insults which can switch cells to adopt an irreversible state of senescence. Interestingly, it is known that senescent cells can induce bystander senescence in the neighboring cells within tissues (Nelson et al. 2012; da Silva et al. 2019). This paracrine senescence is most likely induced by the secretion of SASP factors, such as ROS and cytokines. However, senescent cells possess an increased capacity to secrete extracellular vesicles (EV) which not only target neighboring cells but via the systemic circulation they can expand throughout the whole organism (Nelson et al. 2018; Alibhai et al. 2020; Salminen et al. 2020). Krtolica et al. (2001) demonstrated that senescent fibroblasts promoted the growth of epithelial cells and accordinly stimulated tumorigenesis in mice. Interestingly, there are observations indicating that the EVs secreted from senescent cells are able to enhance immunosuppression in chronic inflammatory conditions (Salminen et al. 2020). It is known that EVs can carry a diverse cargo, e.g., many immunosuppressive miRNAs and other suppressive enhancers, such as ARG1, PGE2, and TGF-β proteins. In fact, the EVs released by tumor cells contain membrane-bound PD-L1 proteins which can act as decoys to confuse the anti-PD-L1 antibodies and thus induce a resistance to immunotherapy (Yin et al. 2021; Chen et al. 2022).

There has been an active debate on the role of the immune system in the elimination of senescent cells, i.e., whether immune cells enhance or prevent the removal of senescent cells. Currently, it is known that there are differences in the clearance process of senescent cells between the microenvironments, such as aging tissues, tumors, and fibrotic lesions (Wang et al. 2022a; Chen et al. 2023; Marin et al. 2023; Lee et al. 2024) (see below). There are several reports indicating that impairments in the function of cytotoxic immune cells, i.e., CD8+ T and NK cells, promote to the accumulation of senescent cells within aged tissues. For instance, Ovadya et al. (2018) demonstrated that deficiency in immunosurveillance activity, evoked either via genetic or pharmacological treatments, disturbed the clearance of senescent cells (SA-β-gal and p16-positive) from tissues in aged mice. The knockout of the perforin gene (Prf−/−), a cytolytic protein expressed in cytotoxic CD8+ T and NK cells, (i) increased cellular senescence in mouse liver, lung, and skin, (ii) enhanced chronic inflammation, and (iii) promoted age-related disorders in several mouse tissues. Moreover, the lack of the Prf gene in progeroid mice shortened their lifespan. They also confirmed that the cytotoxicity of CD8+ T cells was robustly declined in these transgenic mice. These observations indicate that functional deficiencies in surveying immune cells promote the accumulation of senescent cells within aged tissues.

The age-related immunosenescence has been associated with a robust decline in the cytotoxic activity of CD8+ T and NK cells that might impair the elimination of senescent cells (Salminen 2021; Brauning et al. 2022). There is clear evidence that the aging process is associated with activation of the immunosuppressive network intended to inhibit the functions of cytotoxic immune cells (Ruhland et al. 2016; Salminen 2020). Currently, it is known that the age-related immunosuppression can be associated with (i) an increase in the recruitment and differentiation of immunosuppressive cells, such as Tregs, MDSCs, and M2 macrophages, as well as (ii) the activation of inhibitory immune checkpoint signaling, e.g., in the accumulating senescent cells (see below). It is recognized that the immunosuppressive cells secrete anti-inflammatory cytokines, such as TGF-β and IL-10, which inhibit the surveillance activity of CD8+ T and NK cells (Li et al. 2006; Ouyang et al. 2011). For instance, Trzonkowski et al. (2006) demonstrated that Tregs inhibited the cytotoxic activity of human CD8+ T and NK cells. Accordingly, Filippi et al. (2008) revealed that TGF-β exposure suppressed the activation of mouse naïve CD8+ T cells but not that of antigen experienced T cells. Moreover, TGF-β exposure inhibits the cytotoxic activity of NK cells in many experimental models (Viel et al. 2016; Slattery et al. 2021). Nunez et al. (2018) reported that human M2 macrophages reduced the cytotoxic activity of NK cells through the secretion of TGF-β. In their seminal study, Ruhland et al. (2016) demonstrated that senescent stromal cells in mouse skin enhanced inflammation and recruited immunosuppressive Tregs and myeloid-derived suppressor cells (MDSC) into mouse skin. They revealed that senescent stroma in mouse skin robustly decreased immune surveillance of cancer cells and consequently the immunosuppressive environment increased tumorigenesis. Recently, it has been demonstrated that not only immunosuppressive cells but also inhibitory immune checkpoints, such as the PD-1/PD-L1 signaling pathway, can suppress the immune surveillance of senescent cells and thus promote their accumulation with aging (Wang et al. 2022a).

Inhibitory immune checkpoint signaling suppresses immunosurveillance

The immune system drives immune surveillance in the host intended to recognize foreign pathogens as well as aberrant cells, such as malignant and senescent cells. Cytotoxic CD8+ T cells, NK cells and macrophages are the major surveying immune cells which can detect and eliminate not only invading microbes but also abnormal host cells. Antigen presentation via the major histocompatibility complexes (MHC) and the activation of cytotoxic cells are highly regulated processes which are controlled by multilevel regulatory systems (Paul and Lal 2017; Shah et al. 2021). The immune checkpoint receptors fine-tune this process by either stimulating or inhibiting the function of cytotoxic cells. In fact, many checkpoint receptors function as co-receptors which cooperate to maintain the immune balance by regulating the activity of major signaling pathways of cytotoxic cells, such as T cell receptor (TCR) signaling (Baldanzi 2022). For instance, the inhibitory immune checkpoint receptors have an important role in the suppression of autoimmunity disorders, whereas an excessive activity of inhibitory checkpoints prevents the clearance of tumor cells (Toor et al. 2020; Burke et al. 2023).

Inhibitory immune checkpoint receptors

The receptors of the inhibitory immune checkpoints are ligand-activated receptors which are expressed mainly in cytotoxic T and NK cells and macrophages (Ravetch and Lanier 2000; Buckle and Guillerey 2021; Baldanzi 2022; Guo et al. 2023). There are a number of different receptors which possess inhibitory immune activity but I will focus only on those five receptors which are known to act as inhibitory immune checkpoint receptors for the ligand proteins expressed in senescent cells, i.e., programmed cell death protein-1 (PD-1), leukocyte immunoglobulin-like receptor B4 (LILRB4), natural killer cell receptor G2A (NKG2A), T cell immunoglobulin and mucin domain-3 (TIM-3), and signal regulatory protein α (SIRPα). The inhibitory checkpoint receptors are membrane-bound glycoproteins which contain an extracellular Ig-like V domain and a cytoplasmic tail which encompasses the immunoreceptor tyrosine-based inhibitory motifs (ITIM) and tyrosine-based switch motifs (ITSM) (Xu et al. 2021; Baldanzi 2022; Xiang et al. 2024) (Fig. 1). The binding of the ligand to the inhibitory checkpoint receptor induces the phosphorylation of the ITIM or ITSM sites, thus providing the docking sites for the Src-homology-2 (SH2) protein phosphatases, e.g., SHP-1, SHP-2, and SHIP (Xu et al. 2021; Baldanzi 2022; Xiang et al. 2024). Subsequently, these activated phosphatases can dephosphorylate the components of the TCR and costimulatory CD28 pathways, thus suppressing signaling through the TCR axis (Mizuno et al. 2019; Baldanzi 2022). The inhibition of TCR signaling suppresses the activation, proliferation, and cytokine production of CD8+ T cells, thus attenuating immune surveillance and cytotoxic activity. Intriguingly, similar defects in the properties of CD8+ T and NK cells are typical changes encountered in the immunosenescence state which is not only associated with the aging process but also found in tumors and age-related diseases (Barbe-Tuana et al. 2020; Lian et al. 2020; Salminen 2021). Currently, it seems probable that an increase in the expression of ligands for inhibitory checkpoint receptors (discussed below) could reduce the functional efficiency of the immune system and promote immunosenescence. Next, I will briefly describe the properties of certain inhibitory checkpoint pathways and examine whether an increase in the expression of their ligands in senescent cells could impair immunosurveillance and consequently promote the accumulation of senescent cells within aged tissues.Fig. 1 A schematic presentation of the inhibitory immune checkpoint receptors in cytotoxic immune cells and their ligands in senescent cells. CEACAM 1 carcinoembryonic antigen-related cell adhesion molecule 1, Gal galectin, HLA-E human leukocyte antigen-E, HMGB1 high mobility group box 1, ITIM immunoreceptor tyrosine-based inhibitory motif, ITSM immunoreceptor tyrosine-based switch motif, LILRB4 leukocyte immunoglobulin-like receptor B4, NKG2A natural killer cell receptor G2A, PD-1 programmed cell death protein-1, PD-L1 programmed death-ligand 1, SIRPα signal regulatory protein α, TIM-3 T cell immunoglobulin and mucin domain-3

PD-1

The PD-1 receptor (CD279), a member of the immunoglobulin superfamily, is expressed on activated T and B cells, NK cells, and some myeloid cells (Ghosh et al. 2021; Beenen et al. 2022). The two ligands for the PD-1 receptor, PD-L1 (CD274 or B7-H1) and PD-L2 (CD273 or B7-DC), are members of the B7 family of immune regulatory ligand proteins (Collins et al. 2005). The PD-L1 proteins are expressed in several antigen presenting and immunosuppressive cells as well as in many stromal cells, e.g., fibroblasts, pericytes, epithelial, endothelial, and smooth muscle cells (Ghosh et al. 2021, Human Protein Atlas). Moreover, the PD-L1 protein is expressed in senescent cells (Onorati et al. 2022; Wang et al. 2022a) and especially in diverse cancer cells and cancer-associated fibroblasts (CAF) (Jiang et al. 2019; Pei et al. 2023). In tumors, the PD-1/PD-L1 checkpoint signaling has a crucial role in the immune evasion of tumor cells and in the generation of an immunosuppressive microenvironment. The binding of the PD-L1 protein to the PD-1 receptor of CD8+ T cells activates an inhibitory signaling cascade which leads to a loss of cytotoxicity and even promotes the exhaustion of CD8+ T cells. The PD-1/PD-L1 checkpoint axis possesses both beneficial and harmful properties, e.g., it confers immunosuppressive protection in autoimmune diseases, whereas in cancers and fibrotic diseases it provides an immune escape mechanism for abnormal cells to avoid immunosurveillance (Francisco et al. 2010; Toor et al. 2020; Zhao et al. 2023). Currently, the inhibition of the PD-1/PD-L1 signaling with PD-1 and PD-L1 antibodies is a widely used anti-cancer therapy (Tang et al. 2022). However, therapy with PD-1/PD-L1 blockers can induce an immune-based resistance which is due to a loss of PD-L1 expression and defects in antigen presentation and interferon signaling (Vesely et al. 2022). It is known that many combination therapies can improve the treatment response to PD-1/PD-L1 checkpoint inhibitors.

LILRB4

The LILRB4 receptor (ILT3, gp49B) belongs to the leukocyte immunoglobulin-like receptor subfamily B and it contains three inhibitory ITIM domains (Redondo-Garcia et al. 2023; Xiang et al. 2024). The LILRB4 receptor is expressed in T cells, neutrophils, monocytes, macrophages, dendritic cells, microglia, and endothelial cells. The five members of the LILRB family have different specificities for their activating ligands, i.e., the LILRB4 receptor is activated by fibronectin, apolipoprotein E (ApoE), and galectin-8 (Gal-8) (Redondo-Garcia et al. 2023). The activation of LILRB4 signaling enhances the development of an immunosuppressive microenvironment in mouse and human tumors and it facilitates the immune escape of tumor cells (Sharma et al. 2021). Wang et al. (2024b) demonstrated that an exposure to Gal-8 induced the differentiation of mouse monocytes into monocytic MDSCs and subsequently enhanced their expansion through the activation of STAT3 and inhibition of NF-κB signaling. They also revealed that the activation of LILRB4 promoted tumor growth in mice, whereas antibodies blocking the interaction between Gal-8 and LILRB4 receptor suppressed tumor growth in mice. Accordingly, Deng et al. (2018) reported that the signaling via the ApoE/LILRB4/SHP-2/Arginase-1 pathway in mouse myeloid leukemia cells suppressed T cell activity and created an immunosuppressive microenvironment conducive to tumor invasion. Given that the activation of LILRB4 induces immune tolerance, it seems that LILRB4 signaling may well exert beneficial effects in autoimmune diseases, transplantation biology, and maternal–fetal interactions (Xiang et al. 2024).

Fibronectin, a protein abundantly present in the extracellular matrix (ECM), is also a physiological ligand for the immunosuppressive LILRB4 receptor (Itoi et al. 2022; Itagaki et al. 2023; Xiang et al. 2024). In their seminal study, Itoi et al. (2022) demonstrated that fibronectin was tethered with integrins and the LILRB4 receptor on the cell surface of human and mouse macrophages. The terminal 30 kD domain of fibronectin (FN30) interacted with the LILRB4 receptor, whereas the RGD motif could bind the β-integrin protein. Subsequently, they revealed that the cytotoxicity of mouse NK cells was attenuated when the LILRB4 receptor was activated (Itagaki et al. 2023). These experiments indicated that FN30/LILRB4 signaling inhibited the integrin-assisted natural cytotoxicity of NK cells. In addition to some other inhibitory immune checkpoints in NK cells, such as NKG2A (see below), it seems that FN30/LILRB4 signaling can mitigate the cytotoxicity of NK cells and thus inhibit the elimination of cancer cells. Moreover, Paavola et al. (2021) demonstrated that the fibronectin/LILRB4 interaction inhibited the antigen-presentation by human dendritic cells as well as suppressing cytokine production by the Fcγ receptor (FcR)-activated human THP-1 macrophages. These inhibitory effects could be reversed by treatment with an antibody to the LILRB4 receptor. Paavola et al. (2021) also reported that the blockade of LILRB4 signaling robustly increased the secretion of chemokines, such as CCL3, CCL5, and CXCL10, from tumor cells. There is mounting evidence that fibronectin-activated LILRB4 signaling has profound effects on immune responses therefore LILRB4 signaling is a promising target in drug discovery.

NKG2A

The NKG2A receptor is a member of the C-type lectin-like receptor superfamily which includes seven NKG2 receptors, both inhibitory and activating checkpoint receptors (Guo et al. 2023). For instance, the NKG2A receptor is an inhibitory checkpoint in immunosurveillance, whereas the NKG2D receptor is a potent activator of the immune clearance of cancer and senescent cells (Iannello and Raulet 2013; Sagiv et al. 2016). The NKG2A receptor is abundantly expressed on the surface of human NK and CD8+ T cells. Currently, the HLA class I histocompatibility antigen, α chain E (HLA-E) is the sole ligand for the NKG2A receptor (Lee et al. 1998). The expression of the HLA-E protein is enriched on the surfaces of unhealthy cells, such as infected cells as well as tumor and senescent cells. Ljubic et al. (2023) examined the molecular mechanisms in the binding process between the HLA-E ligand and the NKG2A receptor and they revealed that the inhibitory signaling pathways of the NKG2A receptor were mediated via its two ITIM domains. There is clear evidence that the NKG2A/HLA-E complex inhibits the immune surveillance and impairs the clearance of tumor cells by the cytotoxic NK and CD8+ T cells (Andre et al. 2018; Kamiya et al. 2019; Fisher et al. 2022). The blockade of the interaction between the HLA-E and the NKG2A receptor is an important drug discovery target since it can unleash the anti-tumor immunity of cytotoxic NK and CD8+ T cells (Andre et al. 2018; Kamiya et al. 2019). It has been claimed that the immunosuppressive NKG2A/HLA-E axis has an important role in many immune-mediated diseases, such as in tumors, infections, and autoimmune diseases (Wang et al. 2022b).

TIM-3

The TIM-3 receptor, also called hepatitis A virus cellular receptor 2 (HAVCR2), is expressed in T, NK, NKT, and many myeloid cells (Wolf et al. 2020; Buckle and Guillerey 2021). There are several ligands for the TIM-3 receptor, i.e., galectin-9 (Gal-9), phosphatidylserine (PtdSer), high mobility group protein B1 (HMGB1), and carcinoembryonic antigen cell adhesion molecule-1 (CECAM-1) (Wolf et al. 2020; Buckle and Guillerey 2021). The Gal-9 protein is also a ligand for another inhibitory immune checkpoint receptor, i.e., the V-domain immunoglobulin suppressor of T cell activation (VISTA) (Shekari et al. 2023). While the cytoplasmic tail of the TIM-3 receptor lacks the ITIM or ITSM domains, it does contain five conserved tyrosine residues which mediate the downstream inhibitory signaling. The function of TIM-3 is associated with (i) dysfunction and exhaustion of CD8+ T cells by disturbing TCR signaling, (ii) inhibition of the activity of Th1 and Tc1 cells, (iii) induction of antigen-specific tolerance, (iv) suppression of some properties of NK cells, (v) increase in transplantation tolerance, and (vi) inhibition of many activities of the innate immune system (Anderson et al. 2016; Wolf et al. 2020; Buckle and Guillerey 2021). In autoimmune diseases, IFN-β therapy increased the expression of TIM-3 and thus enhanced protective immunity, whereas in chronic viral infections and cancers, TIM-3 expression repressed immunosurveillance and inhibited the immune clearance (Anderson et al. 2016; Wolf et al. 2020). Currently, the TIM-3 receptor is a promising target for immunotherapy, especially in many tumors (Sauer et al. 2023).

The Gal-9 ligand of the TIM-3 receptor is a secreted, β-galactoside-binding protein which also has important intracellular functions linked with its lectin property, e.g., Gal-9 can enhance cytosolic ubiquitination and thus activate AMP kinase (Jia et al. 2020; Wolf et al. 2020). As a ligand for the TIM-3 receptor, Gal-9 was shown to promote immunosuppression, e.g., in human cancers, by triggering an exhaustion of CD8+ T cells and impairing the cytotoxicity of NK cells (Kandel et al. 2021; Yang et al. 2021). Moreover, the Gal-9 protein can enhance the differentiation of immunosuppressive Tregs, whereas it reduces the level of Th17 cells and thus attenuates the severity of mouse collagen-induced arthritis (Seki et al. 2008). The HMGB1 ligand of the TIM-3 receptor is a multifunctional alarmin localized in chromatin structures which is secreted in many pathological states (Tang et al. 2023). When it gains access to the extracellular space, HMGB1 can interact with many immunoreceptors, both immunosuppressive and immunostimulatory. For instance, HMGB1-mediated TIM-3 signaling was able to inhibit the innate immunity responses to nucleic acids induced by Toll-like receptors 3, 7, and 9 in mouse tumors (Chiba et al. 2012). Moreover, it is known that the HMGB1 protein is an important mediator of the senescence phenotype (Davalos et al. 2013). DeKruyff et al. (2010) demonstrated in mice that PtdSer, a membrane phospholipid and a marker of apoptotic cells, is a ligand for the TIM-3 receptor. There are studies indicating that the TIM-3 receptor mediates the phagocytosis of apoptotic cells and consequently induces the cross-presentation of antigens from dying cells (Nakayama et al. 2009; DeKruyff et al. 2010). The membrane-bound CEACAM1 protein is the fourth ligand for the TIM-3 receptor expressed in many immune and non-immune cells (Wolf et al. 2020). CEACAM1 is a multifunctional glycoprotein which has diverse other functions independent of TIM-3 signaling, e.g., it can enhance cell–cell adhesion and control insulin clearance (Kuespert et al. 2006). CEACAM1 also regulates several TIM-3-dependent immune functions. For example, Zhang et al. (2017) demonstrated that CEACAM1 and TIM-3 promoted the exhaustion of CD8+ T cells in colorectal cancer patients. Moreover, the expression of the CEACAM1 protein in activated mouse NK cells inhibited the cytolytic activity of the NKG2D receptor (Hosomi et al. 2013). It seems that it is difficult to develop immunotherapy based on CEACAM1 protein because it is involved in many crucial immune and metabolic functions.

SIRPα

The SIRPα protein is a membrane-bound inhibitory checkpoint receptor which is mainly expressed in myeloid cells, especially in macrophages, although it can also be present in stem cells and neurons (Barclay and Van den Berg 2014; Logtenberg et al. 2020). The SIRPα receptor interacts with the CD47 protein, also called the integrin associated protein (IAP), which is widely expressed in both immune and non-immune cells (Barclay and Van den Berg 2014; Isenberg and Montero 2024). The major function of the SIRPα/CD47 axis is to inhibit the phagocytosis of apoptotic and abnormal cells, i.e., the CD47 protein transmits a “don’t eat me” signal to macrophages via the activation of SIRPα. The cytoplasmic tail of SIRPα contains four conserved tyrosine residues which act as an ITIM domain to block the phagocytosis of apoptotic cells by macrophages (Logtenberg et al. 2020). Tumor cells as well as senescent cells utilize this mechanism to avoid their phagocytosis by macrophages (Jia et al. 2021; Schloesser et al. 2023). The CD47 protein is a potent marker of the “self” and for instance, the Cd47-induced Sirpα signaling in mouse NK cells prevented immunosurveillance and the NK cell-mediated destruction of xenogeneic tissues (Deuse et al. 2021). Moreover, it is known that cancer cells can pack the CD47 protein into extracellular vesicles and thus evade immune surveillance (Shimizu et al. 2021). The activation of SIRPα is reputed to be involved in the pathogenesis of many diseases, such as atherosclerosis, chronic viral infections, and tumor growth (Feng et al. 2023). In addition, the CD47 protein can also serve as a receptor for the matricellular thrombospondin 1 (TSP1) protein which can trigger the CD47-mediated downstream responses thus inducing disturbances in gene expression, mitochondrial function, and many metabolic activities (Roberts and Isenberg 2021). Currently, the downstream signaling mechanisms of the CD47 protein still need to be clarified.

Other inhibitory checkpoint receptors

There are many other inhibitory checkpoint receptors in the immune system (Baldanzi 2022; Guo et al. 2023) although currently there is not enough relevant evidence on whether their ligands are expressed in senescent cells. For instance, many human Siglec receptors contain tyrosine motifs and the ITIM domain and they display many of the properties associated with inhibitory immune checkpoint receptors, e.g., Siglec 5, 7, 10, 15 (Ravetch and Lanier 2000; Guo et al. 2023). It is known that the Siglec/sialic acid axis acts as a glyco-immune checkpoint which can inhibit the functions of many surveying immune cells (Saini et al. 2022) and it has a crucial role in many human diseases (Duan and Paulson 2020). For instance, it is known that cancer cells exploit sialoglycan-Siglec interactions to evade immunosurveillance (van de Wall et al. 2020). However, currently it is not known whether cellular senescence affects the surface sialylation of senescent cells in a way which could provide immune evasion for senescent cells. However, several investigators have reported that the level of many sialoglycans decreases rather than increases with cellular senescence (Tadokoro et al. 2006; Itakura et al. 2016).

Senescent cells evade immune clearance by increasing the expression of ligands for inhibitory immune checkpoint receptors

As described above, the ligands of checkpoint receptors have a crucial role in the immune prevention of host tissues. It seems that cancer cells and senescent cells are able to evade immune surveillance by increasing their expression of the ligand proteins for inhibitory checkpoint receptors. It is known that signaling of many inhibitory checkpoint receptors suppresses the activation of the TCR or B cell receptors (BCR) (Okazaki et al. 2001; Mizuno et al. 2019). There are studies indicating that senescent cells can also increase their antigen presentation by stimulating the expression of proteins of the MHC-I/II machinery (van Tuyn et al. 2017; Chen et al. 2023; Marin et al. 2023; Sinning et al. 2023). For instance, Marin et al. (2023) demonstrated that the cellular senescence induced by three different senescence inducers (genotoxic, CDK4/6 inhibitor, and p53 activator) robustly upregulated antigen presentation via the MHC-I machinery in human IMR-90 fibroblasts and mouse embryonic fibroblasts (MEF) as well as in two human melanoma cell lines. Moreover, tumor senescent cells induced the production of immunogenic peptides which were able to activate CD8+ T-dependent antitumor immunity. However, the immune surveillance performed by CD8+ T and NK cells is dependent on the balance between the function of the stimulatory and inhibitory co-receptors in these cytotoxic cells and it is this balance that determines whether a senescent cell will or will not be eliminated (Chen and Flies 2013; Zhang and Vignali 2016; Baldanzi 2022).

Interestingly, Chen et al. (2023) reported that the p53 activation-induced senescence of mouse hepatic tumors and tumor cells removed their immune resistance and increased their immune clearance. They also revealed that IFNγ signaling promoted the immune surveillance and elimination of senescent tumor cells. Bojko et al. (2019) demonstrated that different chemotherapeutic agents induced diverse senescence phenotypes in respect to different drugs and cancer cell types. It seems that the inducer of senescence state has a crucial role in tumor cell immunogenicity. For instance, Lee et al. (2024) demonstrated that the senescence of human breast cancer cells induced by CDK4/6 inhibitors promoted immunogenic anti-tumor properties, whereas treatment with DNA-damaging agents augmented the pro-tumorigenic microenvironment. This difference was attributable to an increase in the level of SASP factors produced by DNA-damaging treatment. This is an important observation since it is known that pro-inflammatory SASP factors are present in aged tissues and they activate the expression of many inhibitory immune checkpoints, e.g., that of PD-L1 in aged mice, and thus increase the ability of senescent cells to avoid surveillance by cytotoxic immune cells (Wang et al. 2022a). Next, I will examine the expression of the ligands of certain inhibitory immune checkpoint receptors in senescent cells and aged tissues and their effects on the immunosurveillance of senescent cells.

PD-1/PD-L1

There is clear evidence that the expression levels of PD-L1 are increased with aging in many mouse and human tissues, such as cerebellum, cardiac muscle, kidney, liver, lung, and spleen (Benayoun et al. 2019; Garcia et al. 2022; Onorati et al. 2022; Wang et al. 2022a). This is not surprising since it is known that pro-inflammatory SASP mediators are potent inducers of the expression of PD-L1 protein (Antonangeli et al. 2020; Betzler et al. 2020; Rong et al. 2021; Nawas et al. 2023; Salminen 2024). It has been reported that the NF-κB system, especially the non-canonical RelB signaling, as well as JAK-STAT signaling stimulates the expression of the PD-L1 protein (Antonangeli et al. 2020; Onorati et al. 2022; Zhang et al. 2022). Moreover, the NLRP3 inflammasomes, when primed by NF-κB signaling, were observed to be involved in the upregulation of PD-L1 expression and immunosuppression in mouse lymphoma (Lu et al. 2021). Given that the SASP-related inflammatory markers are augmented in many age-related diseases, there are reports indicating that the expression of PD-L1 is upregulated in coronary artery disease (CAD), obstructive lung disease (COPD), and Alzheimer’s disease (AD) (Saresella et al. 2012; Weyand et al. 2018; Polverino et al. 2022). Moreover, it is known that the expression of PD-L1 has an important role in the development of age-related fibrotic lesions in cardiac muscle, kidney, and lungs (Jiang et al. 2022; Onorati et al. 2022; Zhao et al. 2023).

The accumulation of senescent cells seems to be one source of the increased expression of the PD-L1 protein in aged tissues. Onorati et al. (2022) demonstrated that the exposure of cultured human IMR-90 fibroblasts to a wide variety of different inducers of cellular senescence, e.g., replicative exhaustion, etoposide, oncogenic HrasV12, and ionizing radiation, stimulated a robust increase in the expression of the PD-L1 protein in senescent fibroblasts. A cytochemical evaluation of the fibroblasts revealed that there was an intense staining of the PD-L1 protein at the cell-surface of senescent fibroblasts. While it is known that the PD-L1 protein can also accumulate into the nuclei (Hudson et al. 2020), these results clearly indicated that after senescence treatments, the PD-L1 protein was localized to the cell-surface and thus was able to target the PD-1 receptor of immune cells. Interestingly, Onorati et al. (2022) reported that the SASP factors released from cultured senescent fibroblasts were able to induce an upregulation of PD-L1 expression in neighboring cells. They also revealed that secreted factors induced the expression of PD-L1 via the JAK-STAT pathway. Using different imaging techniques, Wang et al. (2022a) demonstrated that with aging the PD-L1-positive cells accumulated within mouse liver and kidney. They also observed that the expression level of PD-L1 correlated with the degree of SASP markers in cells of aged tissues. Interestingly, Wang et al. (2022a) demonstrated that those cells with a high expression level of the PD-L1 protein in cultured mouse pulmonary fibroblasts were protected against the immune surveillance and clearance by cytotoxic CD8+ T cells. This observation indicates that an increase in the expression of the PD-L1 protein in senescent cells was able to reduce the elimination of senescent cells by cytotoxic immune cells.

LILRB4/Fibronectin/Gal-8

Fibronectin is an abundant glycoprotein which binds not only to ECM proteins, such as collagens and some proteoglycans, but also to the cell-membrane bound LILRB4 and integrin receptors (see above). There are many investigations revealing that the aging process affects the properties of fibronectin in aged tissues, i.e., (i) its expression level increases in several cell types in aged tissues (Boyer et al. 1991; Kumazaki et al. 1993; Wicher et al. 2021), (ii) the expression of fibronectin is activated by NF-κB-mediated inflammatory signaling (Qwarnström et al. 1994; Lee et al. 2002), and (iii) the age-related structural alterations occurring in the fibronectin matrix increase the rigidity of the aged ECM (Antia et al. 2008). Interestingly, already two decades before the characterization of the SASP, an increased expression and secretion of fibronectin was identified as a marker of cellular senescence (Shevitz et al. 1986; Smith and Pereira-Smith 1989; Kumazaki et al. 1991). Kumazaki et al. (1993) reported that human fibroblasts in the skin and in human vascular endothelial cells displayed a similar upregulation in the expression of fibronectin both in aged tissues and in cell cultures of replicative senescence. Accordingly, Wang et al. (2015) demonstrated that the replicative senescence of mouse cardiac fibroblasts displayed comparable fibrogenic changes, i.e., an increase in the expression of fibronectin and collagen 1A1 and 3A1, as were evident in the fibroblasts present in the fibrotic myocardium of aged mice. The deposition of fibronectin into tissues in conjunction with pro-inflammatory senescent cells might have a protective role in many inflammatory diseases, e.g., atherosclerosis and autoimmune diseases, since the activation of LILRB4 signaling inhibits NF-κB signaling and moreover, it promotes the activation of immunosuppressive MDSCs (Zhou et al. 2020; Singh et al. 2021; Liu et al. 2023). The pathway of LILRB4, but not those of the integrins, was most probably involved since treatment with the antagonist of the LILRB4 receptor reversed the suppression of T cells induced by human monocytic MDSCs (Singh et al. 2021). Zhou et al. (2020) demonstrated that the activation of LILRB4 signaling protected mouse cardiac muscle from fibrosis and hypertrophy through an inhibition of NF-κB signaling.

Galectins (Gal) are a family of the β-galactoside-binding lectins which have important functions in both intracellular and extracellular spaces. For instance, the Gal-8 protein inhibits the activity of mammalian target of rapamycin (mTOR), an essential regulator of metabolism and physiology (Jia et al. 2018). The Gal-8 protein is highly expressed and secreted in inflammatory conditions and it can regulate many innate and adaptive responses (Tribulatti et al. 2020). Wang et al. (2024b) demonstrated that the Gal-8 protein is a functional ligand for the LILRB4 receptor and it is able to induce the differentiation of M-MDSCs from mouse monocytes by activating the STAT3 pathway and inhibiting NF-κB signaling. The Gal-8 protein is robustly expressed in cancer cells and it is a significant enhancer of the LILRB4-mediated immunosuppressive milieu and the growth of tumors (Wang et al. 2024b). However, there are only a few studies examining the effect of cellular senescence on the expression and secretion of the Gal-8 protein. Wei et al. (2019) revealed that the expression of Gal-8 was robustly increased in senescent human corneal endothelial cells (HCEC) accompanied by senescence markers, such as SA-β-gal and p21. These investigators also revealed that the Gal-8 protein together with matrix metalloproteinase-2 (MMP-2) enhanced the role of senescent HCECs in corneal inflammatory neovascularization (Yu et al. 2019). It seems that in most occasions, the Gal-8 protein as well as the LILRB4 receptor evoked immunosuppression thus promoting cancer growth while alleviating the severity of inflammatory diseases.

NKG2A/HLA-E

Pereira et al. (2019) demonstrated that the cellular senescence induced by replicative senescence, ionising radiation (X-ray), and oncogenic RAS activation stimulated a robust increase in the expression of the HLA-E protein in human fibroblasts and endothelial cells. They also reported that SASP factors, such as cytokines IL-6 and IL-8 as well as chemokine CCL2, induced the expression of HLA-E in human non-senescent fibroblasts. It is known that in human Tera-2 cells, the transcription of the HLA-E gene can be stimulated by IFN-γ signaling via the STAT1 pathway (Gobin and van den Elsen 2000). Pereira et al. (2019) reported that the HLA-E protein targeted the NKG2A receptor on the surface of NK and CD8+ T cells. Subsequently, they revealed that an inhibition of the expression of HLA-E in senescent human fibroblasts enhanced their immune elimination in vitro by NK and CD8+ T cells. Moreover, Pereira et al. (2019) performed histochemical stainings for HLA-E and p16INK4A, a marker of cellular senescence, and they observed that these proteins were co-localized in fibroblasts in the skin samples from aged humans. These results indicate that senescent cells are able to evade immune clearance by NK and CD8+ T cells by stimulating the expression of the HLA-E protein. The HLA-E protein can also be packaged into EVs (Jiang et al. 2021) although currently it is not known whether senescent cells can inhibit cytotoxic cells by secreting the HLA-E protein in EVs, a signaling mechanism known to be activated in senescent cells (Salminen et al. 2020).

TIM-3/HMGB1/Gal-9/CEACAM1

There is abundant evidence that the cellular senescence upregulates the expression of HMGB1, Gal-9, and CEACAM1 in different models. HMGB1 is an alarmin which is secreted from senescent cells and many immune cells during times of tissue stress and inflammation. The HMGB1 protein can bind to certain immunoreceptors, such as TIM-3 and Toll-like receptor 4 (TLR4). Davalos et al. (2013) demonstrated that several treatments that could induce cellular senescence were able to stimulate the secretion of the HMGB1 protein from human fibroblasts. They also observed that senescent cells actively exported nuclear HMGB1 into the extracellular space. It is known that the HMGB1 protein can stimulate inflammatory responses although it seems that it can also inhibit some specific immune responses via the TIM-3 receptor (Chiba et al. 2012; Huang et al. 2022a). As described above, in the cancer microenvironment, the Gal-9 protein inhibits the cytotoxicity of NK and CD8+ T cells via the activation of TIM-3 signaling. Berben et al. (2020) demonstrated that the level of the Gal-9 protein progressively increased with aging in the human blood. Moreover, the Gal-9 protein was an important marker of frailty in old women (Mitchell et al. 2023). Currently, it is not known whether cellular senescence is involved in the increase in the Gal-9 level associated with aging. Tarallo et al. (2024) demonstrated that the temozolomide-induced senescence of mouse melanoma cells robustly increased the expression and secretion of the Gal-9 protein. Interestingly, silencing of mitofusin 1, a mitochondrial fusion protein, reduced the expression of SASP factors, decreased the expression of the Gal-9 protein, promoted immune cell recruitment, and delayed the growth of melanoma. These results indicate that cellular senescence controls the expression level of the Gal-9 protein.

The CEACAM1 protein is upregulated not only in cancer cells but also in diverse types of senescent cells. For instance, Sappino et al. (2012) demonstrated that the inducers of DNA double-strand breaks, such as neocarzinostatin and etoposide, robustly stimulated the expression of CEACAM1 and senescence markers in human epithelial cells and colon cancer cells. They revealed that the upregulation of this protein was mediated through the ATM/p53 signaling pathway. Moreover, they reported that the silencing of CEACAM1 expression impaired the p53-induced cellular senescence. Lee et al. (2024) also demonstrated that two DNA damaging agents, cisplatin and doxorubicin, increased the expression of CEACAM1 and many SASP factors in human breast cancer cells. There are observations indicating that the expression of CEACAM1 promotes vascular aging in humans and mice. For instance, Kleefeldt et al. (2019) reported that the aging process increased the expression of CEACAM1 in human internal thoracic artery and murine aorta. An age-related increase in the expression of CEACAM1 augmented oxidative stress and the expression of TNF-α as well as consequently, it increased collagen accumulation and impaired the integrity of the endothelial barrier. Currently, it is not known whether an increased expression of CEACAM1 is associated with the TIM-3-induced vascular disturbances (Cong et al. 2020).

SIRPα/CD47

Schloesser et al. (2023) demonstrated that an increase in the expression of the CD47 protein was a hallmark of cellular senescence induced by different senescence inducers in many human and mouse fibroblast populations. These results are in agreement with the reports that the expression of CD47 increased with aging in mouse tissues, e.g. in the lungs (Tabula Muris Consortium 2020; Schloesser et al. 2023). This implies that senescent cells upregulate the expression of the marker-of-self, i.e., the CD47 protein, to evade their elimination through phagocytosis. Interestingly, Schloesser et al. (2023) revealed that senescent human fibroblasts were resistant to their efferocytosis by human macrophages. Moreover, they reported that senescent fibroblasts also inhibited the capacity of macrophages to engulf surrounding cell corpses. The suppression of macrophage-induced phagocytosis was dependent on the cell–cell contact with senescent fibroblasts rather than with secreted SASP factors. They also revealed that the inhibition of phagocytic activity of macrophages was attributed to the activation of SHP-1 by means of the ITIM domain in the SIRPα protein. Kojima et al. (2016) reported that exposure to CD47 blocking antibodies restored the phagocytic activity of macrophages and subsequently inhibited the severity of atherosclerosis in mouse models. As described above, the CD47 protein is also a receptor for the TSP1 protein and this regulation mechanism is independent of SIRPα signaling. For instance, TSP1 signaling via the CD47 receptor induces cellular senescence in endothelial cells (Gao et al. 2016; Bitar 2019). Moreover, there are observations indicating that TSP1/CD47 signaling disturbs the normal function of arteries and promotes a vascular aging process. Ghimire et al. (2020) demonstrated that the expression levels of both TSP1 and CD47 significantly increased in human and mouse arteries. They observed that the expression of the CD47 protein reduced the migration of mouse endothelial cell and the formation of capillary tubes. Ghimire et al. (2020) also reported that the angiogenic activity was significantly greater in old CD47-null mice than in their aged wild-type counterparts. The blood flow in the hind limbs was also significantly greater in the CD47-null mice than in wild-type mice. However, it should be emphasized that the TSP1 protein has many other targets which could affect blood flow with aging. In fact, the CD47 protein can act as the ligand for the SIRPα receptor as well as concurrently acting as the receptor of the TSP1 protein.

Cooperation between inhibitory immune checkpoints and immunosuppressive cells

The aging process is associated with a gradual decline and remodelling of the properties of the immune system, i.e., a phenomenon called immunosenescence (Fulop et al. 2018; Salminen 2021; Santoro et al. 2021). However, immunosenescence is not only connected to the aging process since many age-related and chronic inflammatory diseases are associated with a clear immune suppressive state (Kanterman et al. 2012; Barbe-Tuana et al. 2020). Interestingly, an important hallmark of immunosenescence is the decline in the activity of cytotoxic cells, including NK and CD8+ T cells (Martinez-Zamudio et al. 2021; Salminen 2021; Brauning et al. 2022). An accumulation of senescent cells with enriched inhibitory immune checkpoint ligands could represent a mechanism to explain the increase in tissue immunotolerance with aging. Moreover, there is abundant evidence that aged tissues contain an increased number of immunosuppressive cells, such as MDSCs, Tregs, and M2 macrophages (Grizzle et al. 2007; Enioutina et al. 2011; Garg et al. 2014; Ruhland et al. 2016; Salminen 2020, 2022). Currently, it is known that the cooperation between inhibitory immune checkpoint proteins and immunosuppressive cells can inhibit the elimination of senescent cells by cytotoxic NK and CD8+ T cells (Fig. 2).Fig. 2 Cooperation between inhibitory immune checkpoints and immunosuppressive cells. Senescent cells suppress the functions of cytotoxic cells via inhibitory checkpoint ligands. Senescent cells also secrete chemokines which recruit immunosuppressive cells into senescent tissues. Senescent cells can also induce the differentiation of immunosuppressive cells via the PD-1/PD-L1 signaling. On the other hand, immunosuppressive cells secrete anti-inflammatory cytokines which enhance the senescence process itself and stimulate the expression of inhibitory checkpoint ligands in senescent cells. MDSC myeloid-derived suppressor cell, NK natural killer cell. Other abbreviations are as in Fig. 1

Chemokines are well characterized SASP factors secreted by pro-inflammatory senescent cells (Rodier et al. 2009; Freund et al. 2010; Acosta et al. 2013). For instance, cultured senescent cells secrete many members of two families of chemokines, i.e., CCL2,3,5,8 and CXCL1,2,3,5,10. Moreover, granulocyte–macrophage colony-stimulating factor (GM-CSF) is highly secreted by human senescent fibroblasts (Freund et al. 2010). Moreover, single-cell studies have revealed that fibroblasts isolated from aged tissues abundantly express and secrete chemokines (Salzer et al. 2018; Sole-Boldo et al. 2020). The GM-CSF and chemokines secreted from senescent cells induce haematopoiesis in the bone marrow producing myeloid cells which consequently can be recruited into inflamed tissues. For instance, GM-CSF and certain chemokines coordinate the development of immunosuppressive MDSC via myelopoiesis (Li et al. 2022). Accordingly, Hotta et al. (2019) reported that in mice GM-CSF therapy increased the expansion of Tregs. Moreover, it is known that chemokine exposure can augment the polarization of human and mouse M2 macrophages in inflammatory conditions (Mantovani et al. 2004). These studies indicated that senescent cells by secreting GM-CSF and chemokines can recruit and even stimulate the generation of immunosuppressive cells (Fig. 2).

Given that inhibitory immune checkpoints and Tregs have a crucial role in the maintenance of peripheral tolerance, it is not surprising that they are able to cooperate with each other. Francisco et al. (2009) demonstrated that PD-L1 signaling, stimulated by either PD-L1-positive immune cells or PD-L1-bound beads, was able to convert mouse naïve CD4+ T cells into induced Tregs (iTreg). They also reported that iTreg cells suppressed the activity of CD4+ T effector cells. DiDomenico et al. (2018) revealed that mouse PD-L1 ligands stimulated the expansion of iTregs by binding to the PD-1 receptor of the CD4+ T cells. They also reported that the PD-L1-induced Tregs inhibited the proliferation of naïve CD4+ T cells. Moreover, DiDomenico et al. (2018) demonstrated that the blockade of the PD-1 receptor suppressed the expansion of iTregs in a murine glioma model. It is also known that activation of the PD-1/PD-L1 checkpoint pathway stimulated the polarization of macrophages toward the immune suppressive M2 phenotype. Wei et al. (2021) reported that when human THP-1 cells were treated with human recombinant PD-L1 protein, this promoted their polarization toward the M2 macrophage phenotype. The M2 polarization was induced through the ERK/AKT/mTOR signaling pathway in human THP-1 cells. They also revealed that treatment with the PD-1 antagonist, nivolumab, inhibited the PD-L1-induced M2 polarization. There are also indications that the NF-κB-mediated increase in the expression of the PD-1 protein in MDSCs increased their proliferation in the tumor milieu (Nam et al. 2019). It is known that immunosuppressive cells are potent inhibitors of the cytotoxic NK and CD8+ T cells by secreting TGF-β cytokine, a mediator of interactions between immunosuppressive cells (Thomas and Massague 2005; Ralainirina et al. 2007; Flavell et al. 2010). Flavell et al. (2010) have reviewed the role of TGF-β in the suppression of cytotoxicity induced by NK and CD8+ T cells. It seems that the immunosuppressive microenvironment induced by MDSCs, Tregs, and M2 macrophages effectively suppresses the clearance of senescent cells from aged tissues (Fig. 2).

Immunosuppressive cells, either recruited or polarized in aging tissues, secrete anti-inflammatory cytokines, such as TGF-β and IL-10, which can promote the senescence process through two different mechanisms, (i) they can enhance the senescence process itself, or (ii) they can stimulate the expression of inhibitory checkpoint ligands in senescent cells and thus prevent their elimination. Several factors in the senescence microenvironment can activate the latent TGF-β protein, such as reactive oxygen species (ROS) and integrin β3 protein (Frippiat et al. 2001; Rapisarda et al. 2017). Lyu et al. (2018) demonstrated that the ROS-induced TGF-β signaling altered the epigenetic H4K20me3 status by increasing the expression of miR-29 which suppressed the expression of SUV4-20 h and consequently reduced the methylation status of the H4K20me site in mouse embryonic fibroblasts. The loss of H4K20me3 reduced the integrity of DNA and caused a premature fibroblast senescence. They also reported that an increase in TGF/miR-29 signaling promoted the aging process in mouse cardiac muscle. Several other studies have revealed that exposure to TGF-β increased cellular senescence in several experimental models (Tominaga and Suzuki 2019; Matsuda et al. 2023). Cellular senescence is not the only response induced by TGF-β exposure since TGF-β is a robust enhancer of age-related tissue fibrosis (Ren et al. 2023). Moreover, the IL-10 cytokine can also trigger cellular senescence via STAT3 signaling, e.g., in hepatic stellate cells (Huang et al. 2020). These examples indicate that immunosuppressive cells are potent enhancers of cellular senescence both as encountered in aging and in many age-related inflammatory diseases.

Immunosuppressive cells not only enhance cellular senescence but they are also able to stimulate the expression of many inhibitory immune checkpoint proteins, thus promoting immunosenescence in aged tissues (Fig. 2). For instance, Park et al. (2016) demonstrated that TGF-β1 treatment increased the expression of the PD-1 receptors in activated human CD4+ and CD8+ T cells. TGF-β exposure activated the SMAD3 signaling pathway which increased the transcription of the PDCD1 gene. Park et al. (2016) also confirmed that an increase in the expression of PD-1 decreased the function of T cells. Accordingly, Shiri et al. (2024) demonstrated that the IL-10 cytokines secreted by mouse Tregs stimulated the expression of the PD-L1 protein on myeloid cells and subsequently inhibited the immunosurveillance of cancer cells by cytotoxic immune cells. Currently, a dual blockade of the TGF-β and PD-L1 proteins has been used for therapeutic purposes (Gulley et al. 2022). There are several investigations indicating that when human fibroblasts were exposed to TGF-β this stimulated the expression of fibronectin, a major ligand for the LILRB4 receptor (Varga et al. 1987; Roberts et al. 1988). On the other hand, it seems that exposure to TGF-β can inhibit the expression of activating immune checkpoint receptors. Castriconi et al. (2003) demonstrated that the treatment of human NK cells with TGF-β1 inhibited the surface expression of NKp30 and NKG2D receptors, which are major activating checkpoint receptors involved in the immunosurveillance by NK cells. They also confirmed that TGF-β1 exposure prevented the elimination of inducible dendritic cells (iDC). This suggests that TGF-β and probably other immunosuppressive mediators can promote the development of immunosuppressive states in two ways, i.e., either by activating inhibitory checkpoints or inhibiting activating checkpoints.

In conclusion, it seems that the inhibitory checkpoint receptors and their ligands of immune and non-immune cells cooperate with recruited and tissue-resident immunosuppressive cells in aged tissues and in age-related diseases. This immunosuppressive network prevents the elimination of senescent cells from aged tissues. Paradoxically, it seems that pro-inflammatory senescent cells promote tissue inflammation in aged tissues, whereas increased expression of the ligands for inhibitory checkpoint receptors in senescent cells prevents excessive devastating inflammation with aging thus maintaining the chronic low-grade inflammatory state.

Blockade of inhibitory immune checkpoints could provide a novel senolytic therapy

Given that there are studies indicating that the clearance of senescent cells can delay the aging-associated disorders (Baker et al. 2011; Chaib et al. 2022), there has been intensive research to discover either chemical drugs or forms of immunotherapy to eliminate senescent cells from aging tissues (Sikora et al. 2019; Chaib et al. 2022; Krzystyniak et al. 2022). Immunotherapies based on the blockade of inhibitory checkpoints are in clinical use for the treatment of diverse cancers (Shiravand et al. 2022). Antibodies to the PD-1, PD-L1, and CTLA-4 proteins have demonstrated good efficacy in certain cancer types but unfortunately not in all cancers. Currently there are also some small molecule inhibitors and peptides under examination which have been claimed to block the properties of certain inhibitory checkpoint proteins (Fuchs et al. 2024). There are also some preclinical ongoing investigations examining the pros and cons of blockade of immune checkpoints in cardiovascular diseases (Suda et al. 2023), infectious diseases (Wykes and Lewin 2018), and idiopathic pulmonary fibrosis (Tan et al. 2024). Several cancer studies have compared the efficacy of the PD-1/PD-L1 blockade therapy between young and old patients. However, a meta-analysis did not find any differences in treatment efficacy between young and elderly patients (Elias et al. 2018).

The earlier experiments on the elimination of senescent cells used genetic techniques for the removal of senescent cells (Baker et al. 2011). In fact, there are rather few studies which have examined whether the blockade of the PD-1/PD-L1 axis could eliminate senescent cells in tissues, whereas many senolytic trials have utilized chemical approaches (Chaib et al. 2022). Wang et al (2022a) demonstrated that a blockade of the PD-1/PD-L1 axis enhanced immunosurveillance of senescent cells in mouse kidney, liver, and lung and moreover, it also reduced some age-related disorders. They used the anti-PD-1 therapy protocol in aged mice and thus it seems that this treatment prevented the PD-L1-induced exhaustion of CD8+ T cells. Currently, it is known that there are some adverse events, such as systemic inflammatory syndromes, associated with the use of immune checkpoint blockade therapies (Baldini et al. 2020; Zheng 2023). For instance, Baldini et al. (2020) reported that an anti-PD-L1 therapy for solid tumors induced immune-related adverse events more frequently in the elderly than in young patients. This could be attributed to an increase in the expression of the PD-L1 receptor in aged tissues and its wide distribution in the body. Nonetheless, there are many ongoing experiments with inhibitors of other inhibitory checkpoints. For instance, Kojima et al. (2016) demonstrated that the blocking antibodies of the CD47 protein attenuated the severity of atherosclerosis in mouse models by improving the phagocytosis capacity of immune cells and enhanced the clearance of abnormal cells from mouse vascular tissues.

Conclusions

Given that the aging process is associated with a gradual increase in the inflammatory state, it is not surprising that as a counteracting effect there is an activation of immunosuppressive mechanisms, i.e., an increase in the expression of several inhibitory immune checkpoint proteins as well as an upregulation of immunosuppressive cells in tissues, both via recruitment into tissues and alterations in the polarization of tisssue-resident immune cells. Moreover, there are some other mechanisms to counteract increasing inflammation with aging. For instance, an increase in the aging-linked activation of NF-κB system (Salminen et al. 2008a) can be suppressed, e.g., by stimulating the expression of heat-shock proteins HSP70 and HSP90 (Salminen et al. 2008b; van Eden et al. 2017) and inducing an endotoxin tolerance state (Chan et al. 2005). Moreover, it is known that there are many metabolic immune checkpoints, such as the adenosine-induced immunosuppression (Ohta 2016). Currently, the role of cellular senescence in physiology and pathology is under debate; while it seems that it has beneficial effects during embryogenesis and development, however in some pathological conditions, such as in cancer and wound healing, it can evoke both beneficial and harmful responses in a context-dependent manner (Huang et al. 2022b). Currently, it is not known whether the upregulation of inhibitory checkpoint expression is also a context-dependent process with aging. The age-related cellular senescence seems to be a paradoxical process since senescent cells possess both pro-inflammatory and immunosuppressive properties. However, it is known that many signaling pathways which stimulate the expression of the PD-L1 ligand are well-known enhancers of the aging process, such as epigenetic regulation as well as signaling via the mTOR-related, cGAS-STING, and AhR pathways (Salminen 2024). Moreover, the anti-aging treatments with metformin and rapamycin reduce the expression levels of PD-L1 ligand protein. It does seem that inhibitory immune checkpoint signaling has an important role in the aging process.

Acknowledgements

The author thanks Dr. Ewen MacDonald for checking the language of the manuscript.

Author contributions

This article is the sole work of the author.

Funding

Open access funding provided by University of Eastern Finland (including Kuopio University Hospital). The author declares that no funds, grants, or other forms of support were received during the preparation of this manuscript.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Conflict of interest

The author declares that no conflict of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

Acosta JC Banito A Wuestefeld T Georgilis A Janich P Morton JP Athineos D Kang TW Lasitschka F Andrulis M Pascual G Morris KJ Khan S Jin H Dharmalingam G Snijders AP Carroll T Capper D Pritchard C Inman GJ Longerich T Sansom OJ Benitah SA Zender L Gil J A complex secretory program orchestrated by the inflammasome controls paracrine senescence Nat Cell Biol 2013 15 978 990 10.1038/ncb2784 23770676
Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll T, Capper D, Pritchard C, Inman GJ, Longerich T, Sansom OJ, Benitah SA, Zender L, Gil J (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15:978–990. 10.1038/ncb278423770676 10.1038/ncb2784
Alibhai FJ Lim F Yeganeh A DiStefano PV Binesh-Marvasti T Belfiore A Wlodarek L Gustafson D Millar S Li SH Weisel RD Fish JE Li RK Cellular senescence contributes to age-dependent changes in circulating extracellular vesicle cargo and function Aging Cell 2020 19 e13103 10.1111/acel.13103 31960578
Alibhai FJ, Lim F, Yeganeh A, DiStefano PV, Binesh-Marvasti T, Belfiore A, Wlodarek L, Gustafson D, Millar S, Li SH, Weisel RD, Fish JE, Li RK (2020) Cellular senescence contributes to age-dependent changes in circulating extracellular vesicle cargo and function. Aging Cell 19:e13103. 10.1111/acel.1310331960578 10.1111/acel.13103
Anderson AC Joller N Kuchroo VK Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation Immunity 2016 44 989 1004 10.1016/j.immuni.2016.05.001 27192565
Anderson AC, Joller N, Kuchroo VK (2016) Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity 44:989–1004. 10.1016/j.immuni.2016.05.00127192565 10.1016/j.immuni.2016.05.001
Andre P Denis C Soulas C Bourbon-Caillet C Lopez J Arnoux T Blery M Bonnafous C Gauthier L Morel A Rossi B Remark R Breso V Bonnet E Habif G Guia S Lalanne AI Hoffmann C Lantz O Fayette J Boyer-Chammard A Zerbib R Dodion P Ghadially H Jure-Kunkel M Morel Y Herbst R Narni-Mancinelli E Cohen RB Vivier E Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells Cell 2018 175 1731 1743.e13 10.1016/j.cell.2018.10.014 30503213
Andre P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Blery M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E (2018) Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell 175:1731-1743.e13. 10.1016/j.cell.2018.10.01430503213 10.1016/j.cell.2018.10.014
Antia M Baneyx G Kubow KE Vogel V Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response Faraday Discuss 2008 139 229 249 10.1039/b718714a 19048998
Antia M, Baneyx G, Kubow KE, Vogel V (2008) Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss 139:229–249. 10.1039/b718714a. (discussion 309-25, 419-20)19048998 10.1039/b718714a
Antonangeli F Natalini A Garassino MC Sica A Santoni A Di Rosa F Regulation of PD-L1 expression by NF-κB in cancer Front Immunol 2020 11 584626 10.3389/fimmu.2020.584626 33324403
Antonangeli F, Natalini A, Garassino MC, Sica A, Santoni A, Di Rosa F (2020) Regulation of PD-L1 expression by NF-κB in cancer. Front Immunol 11:584626. 10.3389/fimmu.2020.58462633324403 10.3389/fimmu.2020.584626
Baker DJ Wijshake T Tchkonia T LeBrasseur NK Childs BG van de Sluis B Kirkland JL van Deursen JM Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders Nature 2011 479 232 236 10.1038/nature10600 22048312
Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232–236. 10.1038/nature1060022048312 10.1038/nature10600
Baker DJ Childs BG Durik M Wijers ME Sieben CJ Zhong J Saltness RA Jeganathan KB Verzosa GC Pezeshki A Khazaie K Miller JD van Deursen JM Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan Nature 2016 530 184 189 10.1038/nature16932 26840489
Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A, Khazaie K, Miller JD, van Deursen JM (2016) Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530:184–189. 10.1038/nature1693226840489 10.1038/nature16932
Baldanzi G Immune checkpoint receptors signaling in T cells Int J Mol Sci 2022 23 3529 10.3390/ijms23073529 35408889
Baldanzi G (2022) Immune checkpoint receptors signaling in T cells. Int J Mol Sci 23:3529. 10.3390/ijms2307352935408889 10.3390/ijms23073529
Baldini C Martin Romano P Voisin AL Danlos FX Champiat S Laghouati S Kfoury M Vincent H Postel-Vinay S Varga A Vuagnat P Ribrag V Mezquita L Besse B Hollebecque A Lambotte O Michot JM Soria JC Massard C Marabelle A Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies Eur J Cancer 2020 129 71 79 10.1016/j.ejca.2020.01.013 32143106
Baldini C, Martin Romano P, Voisin AL, Danlos FX, Champiat S, Laghouati S, Kfoury M, Vincent H, Postel-Vinay S, Varga A, Vuagnat P, Ribrag V, Mezquita L, Besse B, Hollebecque A, Lambotte O, Michot JM, Soria JC, Massard C, Marabelle A (2020) Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies. Eur J Cancer 129:71–79. 10.1016/j.ejca.2020.01.01332143106 10.1016/j.ejca.2020.01.013
Barbe-Tuana F Funchal G Schmitz CRR Maurmann RM Bauer ME The interplay between immunosenescence and age-related diseases Semin Immunopathol 2020 42 545 557 10.1007/s00281-020-00806-z 32747977
Barbe-Tuana F, Funchal G, Schmitz CRR, Maurmann RM, Bauer ME (2020) The interplay between immunosenescence and age-related diseases. Semin Immunopathol 42:545–557. 10.1007/s00281-020-00806-z32747977 10.1007/s00281-020-00806-z
Barclay AN Van den Berg TK The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target Annu Rev Immunol 2014 32 25 50 10.1146/annurev-immunol-032713-120142 24215318
Barclay AN, Van den Berg TK (2014) The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 32:25–50. 10.1146/annurev-immunol-032713-12014224215318 10.1146/annurev-immunol-032713-120142
Beenen AC Sauerer T Schaft N Dörrie J Beyond cancer: regulation and function of PD-L1 in health and immune-related diseases Int J Mol Sci 2022 23 8599 10.3390/ijms23158599 35955729
Beenen AC, Sauerer T, Schaft N, Dörrie J (2022) Beyond cancer: regulation and function of PD-L1 in health and immune-related diseases. Int J Mol Sci 23:8599. 10.3390/ijms2315859935955729 10.3390/ijms23158599
Benayoun BA Pollina EA Singh PP Mahmoudi S Harel I Casey KM Dulken BW Kundaje A Brunet A Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses Genome Res 2019 29 697 709 10.1101/gr.240093.118 30858345
Benayoun BA, Pollina EA, Singh PP, Mahmoudi S, Harel I, Casey KM, Dulken BW, Kundaje A, Brunet A (2019) Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses. Genome Res 29:697–709. 10.1101/gr.240093.11830858345 10.1101/gr.240093.118
Berben L Floris G Kenis C Dalmasso B Smeets A Vos H Neven P Antoranz Martinez A Laenen A Wildiers H Hatse S Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer Clin Transl Immunology 2020 9 e1184 10.1002/cti2.1184 33024560
Berben L, Floris G, Kenis C, Dalmasso B, Smeets A, Vos H, Neven P, Antoranz Martinez A, Laenen A, Wildiers H, Hatse S (2020) Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer. Clin Transl Immunology 9:e1184. 10.1002/cti2.118433024560 10.1002/cti2.1184
Betzler AC Theodoraki MN Schuler PJ Döscher J Laban S Hoffmann TK Brunner C NF-κB and its role in checkpoint control Int J Mol Sci 2020 21 3949 10.3390/ijms21113949 32486375
Betzler AC, Theodoraki MN, Schuler PJ, Döscher J, Laban S, Hoffmann TK, Brunner C (2020) NF-κB and its role in checkpoint control. Int J Mol Sci 21:3949. 10.3390/ijms2111394932486375 10.3390/ijms21113949
Biran A Zada L Abou Karam P Vadai E Roitman L Ovadya Y Porat Z Krizhanovsky V Quantitative identification of senescent cells in aging and disease Aging Cell 2017 16 661 671 10.1111/acel.12592 28455874
Biran A, Zada L, Abou Karam P, Vadai E, Roitman L, Ovadya Y, Porat Z, Krizhanovsky V (2017) Quantitative identification of senescent cells in aging and disease. Aging Cell 16:661–671. 10.1111/acel.1259228455874 10.1111/acel.12592
Bitar MS Diabetes impairs angiogenesis and induces endothelial cell senescence by up-regulating thrombospondin-CD47-dependent signaling Int J Mol Sci 2019 20 673 10.3390/ijms20030673 30720765
Bitar MS (2019) Diabetes impairs angiogenesis and induces endothelial cell senescence by up-regulating thrombospondin-CD47-dependent signaling. Int J Mol Sci 20:673. 10.3390/ijms2003067330720765 10.3390/ijms20030673
Bojko A Czarnecka-Herok J Charzynska A Dabrowski M Sikora E Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents Cells 2019 8 1501 10.3390/cells8121501 31771226
Bojko A, Czarnecka-Herok J, Charzynska A, Dabrowski M, Sikora E (2019) Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents. Cells 8:1501. 10.3390/cells812150131771226 10.3390/cells8121501
Boyer B Kern P Fourtanier A Labat-Robert J Age-dependent variations of the biosyntheses of fibronectin and fibrous collagens in mouse skin Exp Gerontol 1991 26 375 383 10.1016/0531-5565(91)90049-r 1936196
Boyer B, Kern P, Fourtanier A, Labat-Robert J (1991) Age-dependent variations of the biosyntheses of fibronectin and fibrous collagens in mouse skin. Exp Gerontol 26:375–383. 10.1016/0531-5565(91)90049-r1936196 10.1016/0531-5565(91)90049-r
Brauning A Rae M Zhu G Fulton E Admasu TD Stolzing A Sharma A Aging of the immune system: focus on natural killer cells phenotype and functions Cells 2022 11 1017 10.3390/cells11061017 35326467
Brauning A, Rae M, Zhu G, Fulton E, Admasu TD, Stolzing A, Sharma A (2022) Aging of the immune system: focus on natural killer cells phenotype and functions. Cells 11:1017. 10.3390/cells1106101735326467 10.3390/cells11061017
Buckle I Guillerey C Inhibitory receptors and immune checkpoints regulating natural killer cell responses to cancer Cancers (basel) 2021 13 4263 10.3390/cancers13174263 34503073
Buckle I, Guillerey C (2021) Inhibitory receptors and immune checkpoints regulating natural killer cell responses to cancer. Cancers (basel) 13:4263. 10.3390/cancers1317426334503073 10.3390/cancers13174263
Burke KP Patterson DG Liang D Sharpe AH Immune checkpoint receptors in autoimmunity Curr Opin Immunol 2023 80 102283 10.1016/j.coi.2023.102283 36709596
Burke KP, Patterson DG, Liang D, Sharpe AH (2023) Immune checkpoint receptors in autoimmunity. Curr Opin Immunol 80:102283. 10.1016/j.coi.2023.10228336709596 10.1016/j.coi.2023.102283
Cai N Wu Y Huang Y Induction of accelerated aging in a mouse model Cells 2022 11 1418 10.3390/cells11091418 35563724
Cai N, Wu Y, Huang Y (2022) Induction of accelerated aging in a mouse model. Cells 11:1418. 10.3390/cells1109141835563724 10.3390/cells11091418
Campisi J Robert L Cell senescence: role in aging and age-related diseases Interdiscip Top Gerontol 2014 39 45 61 10.1159/000358899 24862014
Campisi J, Robert L (2014) Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 39:45–61. 10.1159/00035889924862014 10.1159/000358899
Castriconi R Cantoni C Della Chiesa M Vitale M Marcenaro E Conte R Biassoni R Bottino C Moretta L Moretta A Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells Proc Natl Acad Sci U S A 2003 100 4120 4125 10.1073/pnas.0730640100 12646700
Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A (2003) Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 100:4120–4125. 10.1073/pnas.073064010012646700 10.1073/pnas.0730640100
Chaib S Tchkonia T Kirkland JL Cellular senescence and senolytics: the path to the clinic Nat Med 2022 28 1556 1568 10.1038/s41591-022-01923-y 35953721
Chaib S, Tchkonia T, Kirkland JL (2022) Cellular senescence and senolytics: the path to the clinic. Nat Med 28:1556–1568. 10.1038/s41591-022-01923-y35953721 10.1038/s41591-022-01923-y
Chan C Li L McCall CE Yoza BK Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter J Immunol 2005 175 461 468 10.4049/jimmunol.175.1.461 15972680
Chan C, Li L, McCall CE, Yoza BK (2005) Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J Immunol 175:461–468. 10.4049/jimmunol.175.1.46115972680 10.4049/jimmunol.175.1.461
Chen L Flies DB Molecular mechanisms of T cell co-stimulation and co-inhibition Nat Rev Immunol 2013 13 227 242 10.1038/nri3405 23470321
Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227–242. 10.1038/nri340523470321 10.1038/nri3405
Chen J Yang J Wang W Guo D Zhang C Wang S Lu X Huang X Wang P Zhang G Zhang J Wang J Cai Z Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1 Cell Mol Immunol 2022 19 1290 1301 10.1038/s41423-022-00926-6 36220994
Chen J, Yang J, Wang W, Guo D, Zhang C, Wang S, Lu X, Huang X, Wang P, Zhang G, Zhang J, Wang J, Cai Z (2022) Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1. Cell Mol Immunol 19:1290–1301. 10.1038/s41423-022-00926-636220994 10.1038/s41423-022-00926-6
Chen HA Ho YJ Mezzadra R Adrover JM Smolkin R Zhu C Woess K Bernstein N Schmitt G Fong L Luan W Wuest A Tian S Li X Broderick C Hendrickson RC Egeblad M Chen Z Alonso-Curbelo D Lowe SW Senescence rewires microenvironment sensing to facilitate antitumor immunity Cancer Discov 2023 13 432 453 10.1158/2159-8290.CD-22-0528 36302222
Chen HA, Ho YJ, Mezzadra R, Adrover JM, Smolkin R, Zhu C, Woess K, Bernstein N, Schmitt G, Fong L, Luan W, Wuest A, Tian S, Li X, Broderick C, Hendrickson RC, Egeblad M, Chen Z, Alonso-Curbelo D, Lowe SW (2023) Senescence rewires microenvironment sensing to facilitate antitumor immunity. Cancer Discov 13:432–453. 10.1158/2159-8290.CD-22-052836302222 10.1158/2159-8290.CD-22-0528
Chiba S Baghdadi M Akiba H Yoshiyama H Kinoshita I Dosaka-Akita H Fujioka Y Ohba Y Gorman JV Colgan JD Hirashima M Uede T Takaoka A Yagita H Jinushi M Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 Nat Immunol 2012 13 832 842 10.1038/ni.2376 22842346
Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13:832–842. 10.1038/ni.237622842346 10.1038/ni.2376
Chin T Lee XE Ng PY Lee Y Dreesen O The role of cellular senescence in skin aging and age-related skin pathologies Front Physiol 2023 14 1297637 10.3389/fphys.2023.1297637 38074322
Chin T, Lee XE, Ng PY, Lee Y, Dreesen O (2023) The role of cellular senescence in skin aging and age-related skin pathologies. Front Physiol 14:1297637. 10.3389/fphys.2023.129763738074322 10.3389/fphys.2023.1297637
Collins M Ling V Carreno BM The B7 family of immune-regulatory ligands Genome Biol 2005 6 223 10.1186/gb-2005-6-6-223 15960813
Collins M, Ling V, Carreno BM (2005) The B7 family of immune-regulatory ligands. Genome Biol 6:223. 10.1186/gb-2005-6-6-22315960813 10.1186/gb-2005-6-6-223
Cong Y Wang X Wang S Qiao G Li Y Cao J Jiang W Cui Y Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells Biosci Rep 2020 40 10 BSR20202130 10.1042/BSR20202130 33015716
Cong Y, Wang X, Wang S, Qiao G, Li Y, Cao J, Jiang W, Cui Y (2020) Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells. Biosci Rep 40(10):BSR20202130. 10.1042/BSR2020213033015716 10.1042/BSR20202130
da Silva PFL Ogrodnik M Kucheryavenko O Glibert J Miwa S Cameron K Ishaq A Saretzki G Nagaraja-Grellscheid S Nelson G von Zglinicki T The bystander effect contributes to the accumulation of senescent cells in vivo Aging Cell 2019 18 e12848 10.1111/acel.12848 30462359
da Silva PFL, Ogrodnik M, Kucheryavenko O, Glibert J, Miwa S, Cameron K, Ishaq A, Saretzki G, Nagaraja-Grellscheid S, Nelson G, von Zglinicki T (2019) The bystander effect contributes to the accumulation of senescent cells in vivo. Aging Cell 18:e12848. 10.1111/acel.1284830462359 10.1111/acel.12848
Davalos AR Kawahara M Malhotra GK Schaum N Huang J Ved U Beausejour CM Coppe JP Rodier F Campisi J p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes J Cell Biol 2013 201 613 629 10.1083/jcb.201206006 23649808
Davalos AR, Kawahara M, Malhotra GK, Schaum N, Huang J, Ved U, Beausejour CM, Coppe JP, Rodier F, Campisi J (2013) p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol 201:613–629. 10.1083/jcb.20120600623649808 10.1083/jcb.201206006
DeKruyff RH Bu X Ballesteros A Santiago C Chim YL Lee HH Karisola P Pichavant M Kaplan GG Umetsu DT Freeman GJ Casasnovas JM T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells J Immunol 2010 184 1918 1930 10.4049/jimmunol.0903059 20083673
DeKruyff RH, Bu X, Ballesteros A, Santiago C, Chim YL, Lee HH, Karisola P, Pichavant M, Kaplan GG, Umetsu DT, Freeman GJ, Casasnovas JM (2010) T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 184:1918–1930. 10.4049/jimmunol.090305920083673 10.4049/jimmunol.0903059
Deng M Gui X Kim J Xie L Chen W Li Z He L Chen Y Chen H Luo W Lu Z Xie J Churchill H Xu Y Zhou Z Wu G Yu C John S Hirayasu K Nguyen N Liu X Huang F Li L Deng H Tang H Sadek AH Zhang L Huang T Zou Y Chen B Zhu H Arase H Xia N Jiang Y Collins R You MJ Homsi J Unni N Lewis C Chen GQ Fu YX Liao XC An Z Zheng J Zhang N Zhang CC LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration Nature 2018 562 605 609 10.1038/s41586-018-0615-z 30333625
Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W, Lu Z, Xie J, Churchill H, Xu Y, Zhou Z, Wu G, Yu C, John S, Hirayasu K, Nguyen N, Liu X, Huang F, Li L, Deng H, Tang H, Sadek AH, Zhang L, Huang T, Zou Y, Chen B, Zhu H, Arase H, Xia N, Jiang Y, Collins R, You MJ, Homsi J, Unni N, Lewis C, Chen GQ, Fu YX, Liao XC, An Z, Zheng J, Zhang N, Zhang CC (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 562:605–609. 10.1038/s41586-018-0615-z30333625 10.1038/s41586-018-0615-z
Deuse T Hu X Agbor-Enoh S Jang MK Alawi M Saygi C Gravina A Tediashvili G Nguyen VQ Liu Y Valantine H Lanier LL Schrepfer S The SIRPα-CD47 immune checkpoint in NK cells J Exp Med 2021 218 e20200839 10.1084/jem.20200839 33416832
Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, Gravina A, Tediashvili G, Nguyen VQ, Liu Y, Valantine H, Lanier LL, Schrepfer S (2021) The SIRPα-CD47 immune checkpoint in NK cells. J Exp Med 218:e20200839. 10.1084/jem.2020083933416832 10.1084/jem.20200839
DiDomenico J Lamano JB Oyon D Li Y Veliceasa D Kaur G Ampie L Choy W Lamano JB Bloch O The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma Oncoimmunology 2018 7 e1448329 10.1080/2162402X.2018.1448329 29900065
DiDomenico J, Lamano JB, Oyon D, Li Y, Veliceasa D, Kaur G, Ampie L, Choy W, Lamano JB, Bloch O (2018) The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma. Oncoimmunology 7:e1448329. 10.1080/2162402X.2018.144832929900065 10.1080/2162402X.2018.1448329
Dmitrieva NI Burg MB High NaCl promotes cellular senescence Cell Cycle 2007 6 3108 3113 10.4161/cc.6.24.5084 18073528
Dmitrieva NI, Burg MB (2007) High NaCl promotes cellular senescence. Cell Cycle 6:3108–3113. 10.4161/cc.6.24.508418073528 10.4161/cc.6.24.5084
Duan S Paulson JC Siglecs as immune cell checkpoints in disease Annu Rev Immunol 2020 38 365 395 10.1146/annurev-immunol-102419-035900 31986070
Duan S, Paulson JC (2020) Siglecs as immune cell checkpoints in disease. Annu Rev Immunol 38:365–395. 10.1146/annurev-immunol-102419-03590031986070 10.1146/annurev-immunol-102419-035900
Elias R Giobbie-Hurder A McCleary NJ Ott P Hodi FS Rahma O Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis J Immunother Cancer 2018 6 26 10.1186/s40425-018-0336-8 29618381
Elias R, Giobbie-Hurder A, McCleary NJ, Ott P, Hodi FS, Rahma O (2018) Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis. J Immunother Cancer 6:26. 10.1186/s40425-018-0336-829618381 10.1186/s40425-018-0336-8
Enioutina EY Bareyan D Daynes RA A role for immature myeloid cells in immune senescence J Immunol 2011 186 697 707 10.4049/jimmunol.1002987 21148798
Enioutina EY, Bareyan D, Daynes RA (2011) A role for immature myeloid cells in immune senescence. J Immunol 186:697–707. 10.4049/jimmunol.100298721148798 10.4049/jimmunol.1002987
Feng Y Huang C Wang Y Chen J SIRPα: A key player in innate immunity Eur J Immunol 2023 53 e2350375 10.1002/eji.202350375 37672390
Feng Y, Huang C, Wang Y, Chen J (2023) SIRPα: A key player in innate immunity. Eur J Immunol 53:e2350375. 10.1002/eji.20235037537672390 10.1002/eji.202350375
Filippi CM Juedes AE Oldham JE Ling E Togher L Peng Y Flavell RA von Herrath MG Transforming growth factor-β suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity Diabetes 2008 57 2684 2692 10.2337/db08-0609 18689691
Filippi CM, Juedes AE, Oldham JE, Ling E, Togher L, Peng Y, Flavell RA, von Herrath MG (2008) Transforming growth factor-β suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. Diabetes 57:2684–2692. 10.2337/db08-060918689691 10.2337/db08-0609
Fisher JG Doyle ADP Graham LV Khakoo SI Blunt MD Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against cancer Vaccines (basel) 2022 10 1993 10.3390/vaccines10121993 36560403
Fisher JG, Doyle ADP, Graham LV, Khakoo SI, Blunt MD (2022) Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against cancer. Vaccines (basel) 10:1993. 10.3390/vaccines1012199336560403 10.3390/vaccines10121993
Flavell RA Sanjabi S Wrzesinski SH Licona-Limon P The polarization of immune cells in the tumour environment by TGFβ Nat Rev Immunol 2010 10 554 567 10.1038/nri2808 20616810
Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P (2010) The polarization of immune cells in the tumour environment by TGFβ. Nat Rev Immunol 10:554–567. 10.1038/nri280820616810 10.1038/nri2808
Franceschi C Garagnani P Parini P Giuliani C Santoro A Inflammaging: a new immune-metabolic viewpoint for age-related diseases Nat Rev Endocrinol 2018 14 576 590 10.1038/s41574-018-0059-4 30046148
Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576–590. 10.1038/s41574-018-0059-430046148 10.1038/s41574-018-0059-4
Francisco LM Salinas VH Brown KE Vanguri VK Freeman GJ Kuchroo VK Sharpe AH PD-L1 regulates the development, maintenance, and function of induced regulatory T cells J Exp Med 2009 206 3015 3029 10.1084/jem.20090847 20008522
Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206:3015–3029. 10.1084/jem.2009084720008522 10.1084/jem.20090847
Francisco LM Sage PT Sharpe AH The PD-1 pathway in tolerance and autoimmunity Immunol Rev 2010 236 219 242 10.1111/j.1600-065X.2010.00923.x 20636820
Francisco LM, Sage PT, Sharpe AH (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236:219–242. 10.1111/j.1600-065X.2010.00923.x20636820 10.1111/j.1600-065X.2010.00923.x
Freund A Orjalo AV Desprez PY Campisi J Inflammatory networks during cellular senescence: causes and consequences Trends Mol Med 2010 16 238 246 10.1016/j.molmed.2010.03.003 20444648
Freund A, Orjalo AV, Desprez PY, Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16:238–246. 10.1016/j.molmed.2010.03.00320444648 10.1016/j.molmed.2010.03.003
Frippiat C Chen QM Zdanov S Magalhaes JP Remacle J Toussaint O Subcytotoxic H2O2 stress triggers a release of transforming growth factor-β1, which induces biomarkers of cellular senescence of human diploid fibroblasts J Biol Chem 2001 276 2531 2537 10.1074/jbc.M006809200 11060295
Frippiat C, Chen QM, Zdanov S, Magalhaes JP, Remacle J, Toussaint O (2001) Subcytotoxic H2O2 stress triggers a release of transforming growth factor-β1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 276:2531–2537. 10.1074/jbc.M00680920011060295 10.1074/jbc.M006809200
Fuchs N Zhang L Calvo-Barreiro L Kuncewicz K Gabr M Inhibitors of immune checkpoints: Small molecule- and peptide-based approaches J Pers Med 2024 14 68 10.3390/jpm14010068 38248769
Fuchs N, Zhang L, Calvo-Barreiro L, Kuncewicz K, Gabr M (2024) Inhibitors of immune checkpoints: Small molecule- and peptide-based approaches. J Pers Med 14:68. 10.3390/jpm1401006838248769 10.3390/jpm14010068
Fulop T Larbi A Dupuis G Le Page A Frost EH Cohen AA Witkowski JM Franceschi C Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes? Front Immunol 2018 8 1960 10.3389/fimmu.2017.01960 29375577
Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, Witkowski JM, Franceschi C (2018) Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes? Front Immunol 8:1960. 10.3389/fimmu.2017.0196029375577 10.3389/fimmu.2017.01960
Gao Q Chen K Gao L Zheng Y Yang YG Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells Cell Death Dis 2016 7 e2368 10.1038/cddis.2016.155 27607583
Gao Q, Chen K, Gao L, Zheng Y, Yang YG (2016) Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells. Cell Death Dis 7:e2368. 10.1038/cddis.2016.15527607583 10.1038/cddis.2016.155
Garcia MG Deng Y Murray C Reyes RM Padron A Bai H Kancharla A Gupta H Shen-Orr S Curiel TJ Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice Aging Cancer 2022 3 68 83 10.1002/aac2.12045 36876140
Garcia MG, Deng Y, Murray C, Reyes RM, Padron A, Bai H, Kancharla A, Gupta H, Shen-Orr S, Curiel TJ (2022) Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging Cancer 3:68–83. 10.1002/aac2.1204536876140 10.1002/aac2.12045
Garg SK Delaney C Toubai T Ghosh A Reddy P Banerjee R Yung R Aging is associated with increased regulatory T-cell function Aging Cell 2014 13 441 448 10.1111/acel.12191 24325345
Garg SK, Delaney C, Toubai T, Ghosh A, Reddy P, Banerjee R, Yung R (2014) Aging is associated with increased regulatory T-cell function. Aging Cell 13:441–448. 10.1111/acel.1219124325345 10.1111/acel.12191
Ghimire K Li Y Chiba T Julovi SM Li J Ross MA Straub AC O’Connell PJ Rüegg C Pagano PJ Isenberg JS Rogers NM CD47 promotes age-associated deterioration in angiogenesis, blood flow and glucose homeostasis Cells 2020 9 1695 10.3390/cells9071695 32679764
Ghimire K, Li Y, Chiba T, Julovi SM, Li J, Ross MA, Straub AC, O’Connell PJ, Rüegg C, Pagano PJ, Isenberg JS, Rogers NM (2020) CD47 promotes age-associated deterioration in angiogenesis, blood flow and glucose homeostasis. Cells 9:1695. 10.3390/cells907169532679764 10.3390/cells9071695
Ghosh C Luong G Sun Y A snapshot of the PD-1/PD-L1 pathway J Cancer 2021 12 2735 2746 10.7150/jca.57334 33854633
Ghosh C, Luong G, Sun Y (2021) A snapshot of the PD-1/PD-L1 pathway. J Cancer 12:2735–2746. 10.7150/jca.5733433854633 10.7150/jca.57334
Gobin SJ van den Elsen PJ Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G Hum Immunol 2000 61 1102 1107 10.1016/s0198-8859(00)00198-1 11137213
Gobin SJ, van den Elsen PJ (2000) Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol 61:1102–1107. 10.1016/s0198-8859(00)00198-111137213 10.1016/s0198-8859(00)00198-1
Gonzalez-Gualda E Baker AG Fruk L Munoz-Espín D A guide to assessing cellular senescence in vitro and in vivo FEBS J 2021 288 56 80 10.1111/febs.15570 32961620
Gonzalez-Gualda E, Baker AG, Fruk L, Munoz-Espín D (2021) A guide to assessing cellular senescence in vitro and in vivo. FEBS J 288:56–80. 10.1111/febs.1557032961620 10.1111/febs.15570
Gorgoulis V Adams PD Alimonti A Bennett DC Bischof O Bishop C Campisi J Collado M Evangelou K Ferbeyre G Gil J Hara E Krizhanovsky V Jurk D Maier AB Narita M Niedernhofer L Passos JF Robbins PD Schmitt CA Sedivy J Vougas K von Zglinicki T Zhou D Serrano M Demaria M Cellular senescence: defining a path forward Cell 2019 179 813 827 10.1016/j.cell.2019.10.005 31675495
Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, Gil J, Hara E, Krizhanovsky V, Jurk D, Maier AB, Narita M, Niedernhofer L, Passos JF, Robbins PD, Schmitt CA, Sedivy J, Vougas K, von Zglinicki T, Zhou D, Serrano M, Demaria M (2019) Cellular senescence: defining a path forward. Cell 179:813–827. 10.1016/j.cell.2019.10.00531675495 10.1016/j.cell.2019.10.005
Grizzle WE Xu X Zhang S Stockard CR Liu C Yu S Wang J Mountz JD Zhang HG Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice Mech Ageing Dev 2007 128 672 680 10.1016/j.mad.2007.10.003 18036633
Grizzle WE, Xu X, Zhang S, Stockard CR, Liu C, Yu S, Wang J, Mountz JD, Zhang HG (2007) Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 128:672–680. 10.1016/j.mad.2007.10.00318036633 10.1016/j.mad.2007.10.003
Gulley JL Schlom J Barcellos-Hoff MH Wang XJ Seoane J Audhuy F Lan Y Dussault I Moustakas A Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment Mol Oncol 2022 16 2117 2134 10.1002/1878-0261.13146 34854206
Gulley JL, Schlom J, Barcellos-Hoff MH, Wang XJ, Seoane J, Audhuy F, Lan Y, Dussault I, Moustakas A (2022) Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment. Mol Oncol 16:2117–2134. 10.1002/1878-0261.1314634854206 10.1002/1878-0261.13146
Guo Z Zhang R Yang AG Zheng G Diversity of immune checkpoints in cancer immunotherapy Front Immunol 2023 14 1121285 10.3389/fimmu.2023.1121285 36960057
Guo Z, Zhang R, Yang AG, Zheng G (2023) Diversity of immune checkpoints in cancer immunotherapy. Front Immunol 14:1121285. 10.3389/fimmu.2023.112128536960057 10.3389/fimmu.2023.1121285
Hernandez-Segura A Nehme J Demaria M Hallmarks of cellular senescence Trends Cell Biol 2018 28 436 453 10.1016/j.tcb.2018.02.001 29477613
Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28:436–453. 10.1016/j.tcb.2018.02.00129477613 10.1016/j.tcb.2018.02.001
Hosomi S Chen Z Baker K Chen L Huang YH Olszak T Zeissig S Wang JH Mandelboim O Beauchemin N Lanier LL Blumberg RS CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling Eur J Immunol 2013 43 2473 2483 10.1002/eji.201242676 23696226
Hosomi S, Chen Z, Baker K, Chen L, Huang YH, Olszak T, Zeissig S, Wang JH, Mandelboim O, Beauchemin N, Lanier LL, Blumberg RS (2013) CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur J Immunol 43:2473–2483. 10.1002/eji.20124267623696226 10.1002/eji.201242676
Hotchkiss RS Monneret G Payen D Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy Nat Rev Immunol 2013 13 862 874 10.1038/nri3552 24232462
Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874. 10.1038/nri355224232462 10.1038/nri3552
Hotta M Yoshimura H Satake A Tsubokura Y Ito T Nomura S GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells Eur J Immunol 2019 49 179 191 10.1002/eji.201847684 30457669
Hotta M, Yoshimura H, Satake A, Tsubokura Y, Ito T, Nomura S (2019) GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells. Eur J Immunol 49:179–191. 10.1002/eji.20184768430457669 10.1002/eji.201847684
Huang YH Chen MH Guo QL Chen ZX Chen QD Wang XZ Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis Cell Signal 2020 66 109445 10.1016/j.cellsig.2019.109445 31730896
Huang YH, Chen MH, Guo QL, Chen ZX, Chen QD, Wang XZ (2020) Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis. Cell Signal 66:109445. 10.1016/j.cellsig.2019.10944531730896 10.1016/j.cellsig.2019.109445
Huang S Liu D Sun J Zhang H Zhang J Wang Q Gan L Qu G Qiu J Deng J Jiang J Zeng L Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells Mol Ther 2022 30 1227 1238 10.1016/j.ymthe.2021.12.013 34933101
Huang S, Liu D, Sun J, Zhang H, Zhang J, Wang Q, Gan L, Qu G, Qiu J, Deng J, Jiang J, Zeng L (2022a) Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells. Mol Ther 30:1227–1238. 10.1016/j.ymthe.2021.12.01334933101 10.1016/j.ymthe.2021.12.013
Huang W Hickson LJ Eirin A Kirkland JL Lerman LO Cellular senescence: the good, the bad and the unknown Nat Rev Nephrol 2022 18 611 627 10.1038/s41581-022-00601-z 35922662
Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO (2022b) Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol 18:611–627. 10.1038/s41581-022-00601-z35922662 10.1038/s41581-022-00601-z
Hudson K Cross N Jordan-Mahy N Leyland R The extrinsic and intrinsic roles of PD-L1 and its receptor PD-1: Implications for immunotherapy treatment Front Immunol 2020 11 568931 10.3389/fimmu.2020.568931 33193345
Hudson K, Cross N, Jordan-Mahy N, Leyland R (2020) The extrinsic and intrinsic roles of PD-L1 and its receptor PD-1: Implications for immunotherapy treatment. Front Immunol 11:568931. 10.3389/fimmu.2020.56893133193345 10.3389/fimmu.2020.568931
Iannello A Raulet DH Immune surveillance of unhealthy cells by natural killer cells Cold Spring Harb Symp Quant Biol 2013 78 249 257 10.1101/sqb.2013.78.020255 24135717
Iannello A, Raulet DH (2013) Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harb Symp Quant Biol 78:249–257. 10.1101/sqb.2013.78.02025524135717 10.1101/sqb.2013.78.020255
Idda ML McClusky WG Lodde V Munk R Abdelmohsen K Rossi M Gorospe M Survey of senescent cell markers with age in human tissues Aging 2020 12 4052 4066 10.18632/aging.102903 32160592
Idda ML, McClusky WG, Lodde V, Munk R, Abdelmohsen K, Rossi M, Gorospe M (2020) Survey of senescent cell markers with age in human tissues. Aging 12:4052–4066. 10.18632/aging.10290332160592 10.18632/aging.102903
Isenberg JS Montero E Tolerating CD47 Clin Transl Med 2024 14 e1584 10.1002/ctm2.1584 38362603
Isenberg JS, Montero E (2024) Tolerating CD47. Clin Transl Med 14:e1584. 10.1002/ctm2.158438362603 10.1002/ctm2.1584
Itagaki F Nakatsuka K Sakai H Endo S Su MT Takai T Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B Int Immunol 2023 35 339 348 10.1093/intimm/dxad012 37083755
Itagaki F, Nakatsuka K, Sakai H, Endo S, Su MT, Takai T (2023) Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B. Int Immunol 35:339–348. 10.1093/intimm/dxad01237083755 10.1093/intimm/dxad012
Itakura Y Sasaki N Kami D Gojo S Umezawa A Toyoda M N- and O-glycan cell surface protein modifications associated with cellular senescence and human aging Cell Biosci 2016 6 14 10.1186/s13578-016-0079-5 26893823
Itakura Y, Sasaki N, Kami D, Gojo S, Umezawa A, Toyoda M (2016) N- and O-glycan cell surface protein modifications associated with cellular senescence and human aging. Cell Biosci 6:14. 10.1186/s13578-016-0079-526893823 10.1186/s13578-016-0079-5
Ito T Igaki T Dissecting cellular senescence and SASP in Drosophila Inflamm Regen 2016 36 25 10.1186/s41232-016-0031-4 29259698
Ito T, Igaki T (2016) Dissecting cellular senescence and SASP in Drosophila. Inflamm Regen 36:25. 10.1186/s41232-016-0031-429259698 10.1186/s41232-016-0031-4
Itoi S Takahashi N Saito H Miyata Y Su MT Kezuka D Itagaki F Endo S Fujii H Harigae H Sakamoto Y Takai T Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages Int Immunol 2022 34 435 444 10.1093/intimm/dxac023 35689642
Itoi S, Takahashi N, Saito H, Miyata Y, Su MT, Kezuka D, Itagaki F, Endo S, Fujii H, Harigae H, Sakamoto Y, Takai T (2022) Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages. Int Immunol 34:435–444. 10.1093/intimm/dxac02335689642 10.1093/intimm/dxac023
Jackaman C Radley-Crabb HG Soffe Z Shavlakadze T Grounds MD Nelson DJ Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice Aging Cell 2013 12 345 357 10.1111/acel.12062 23442123
Jackaman C, Radley-Crabb HG, Soffe Z, Shavlakadze T, Grounds MD, Nelson DJ (2013) Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell 12:345–357. 10.1111/acel.1206223442123 10.1111/acel.12062
Jia J Abudu YP Claude-Taupin A Gu Y Kumar S Choi SW Peters R Mudd MH Allers L Salemi M Phinney B Johansen T Deretic V Galectins control mTOR in response to endomembrane damage Mol Cell 2018 70 120 135.e8 10.1016/j.molcel.2018.03.009 29625033
Jia J, Abudu YP, Claude-Taupin A, Gu Y, Kumar S, Choi SW, Peters R, Mudd MH, Allers L, Salemi M, Phinney B, Johansen T, Deretic V (2018) Galectins control mTOR in response to endomembrane damage. Mol Cell 70:120-135.e8. 10.1016/j.molcel.2018.03.00929625033 10.1016/j.molcel.2018.03.009
Jia J Bissa B Brecht L Allers L Choi SW Gu Y Zbinden M Burge MR Timmins G Hallows K Behrends C Deretic V AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system Mol Cell 2020 77 951 969.e9 10.1016/j.molcel.2019.12.028 31995728
Jia J, Bissa B, Brecht L, Allers L, Choi SW, Gu Y, Zbinden M, Burge MR, Timmins G, Hallows K, Behrends C, Deretic V (2020) AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system. Mol Cell 77:951-969.e9. 10.1016/j.molcel.2019.12.02831995728 10.1016/j.molcel.2019.12.028
Jia X Yan B Tian X Liu Q Jin J Shi J Hou Y CD47/SIRPα pathway mediates cancer immune escape and immunotherapy Int J Biol Sci 2021 17 3281 3287 10.7150/ijbs.60782 34512146
Jia X, Yan B, Tian X, Liu Q, Jin J, Shi J, Hou Y (2021) CD47/SIRPα pathway mediates cancer immune escape and immunotherapy. Int J Biol Sci 17:3281–3287. 10.7150/ijbs.6078234512146 10.7150/ijbs.60782
Jiang X Wang J Deng X Xiong F Ge J Xiang B Wu X Ma J Zhou M Li X Li Y Li G Xiong W Guo C Zeng Z Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape Mol Cancer 2019 18 10 10.1186/s12943-018-0928-4 30646912
Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z (2019) Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Mol Cancer 18:10. 10.1186/s12943-018-0928-430646912 10.1186/s12943-018-0928-4
Jiang L Fei H Jin X Liu X Yang C Li C Chen J Yang A Zhu J Wang H Fei X Zhang S Extracellular vesicle-mediated secretion of HLA-E by trophoblasts maintains pregnancy by regulating the metabolism of decidual NK cells Int J Biol Sci 2021 17 4377 4395 10.7150/ijbs.63390 34803505
Jiang L, Fei H, Jin X, Liu X, Yang C, Li C, Chen J, Yang A, Zhu J, Wang H, Fei X, Zhang S (2021) Extracellular vesicle-mediated secretion of HLA-E by trophoblasts maintains pregnancy by regulating the metabolism of decidual NK cells. Int J Biol Sci 17:4377–4395. 10.7150/ijbs.6339034803505 10.7150/ijbs.63390
Jiang A Liu N Wang J Zheng X Ren M Zhang W Yao Y The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: friend or foe? Front Immunol 2022 13 1022228 10.3389/fimmu.2022.1022228 36544757
Jiang A, Liu N, Wang J, Zheng X, Ren M, Zhang W, Yao Y (2022) The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: friend or foe? Front Immunol 13:1022228. 10.3389/fimmu.2022.102222836544757 10.3389/fimmu.2022.1022228
Kamiya T Seow SV Wong D Robinson M Campana D Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells J Clin Invest 2019 129 2094 2106 10.1172/JCI123955 30860984
Kamiya T, Seow SV, Wong D, Robinson M, Campana D (2019) Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest 129:2094–2106. 10.1172/JCI12395530860984 10.1172/JCI123955
Kandel S Adhikary P Li G Cheng K The TIM3/Gal9 signaling pathway: an emerging target for cancer immunotherapy Cancer Lett 2021 510 67 78 10.1016/j.canlet.2021.04.011 33895262
Kandel S, Adhikary P, Li G, Cheng K (2021) The TIM3/Gal9 signaling pathway: an emerging target for cancer immunotherapy. Cancer Lett 510:67–78. 10.1016/j.canlet.2021.04.01133895262 10.1016/j.canlet.2021.04.011
Kanterman J Sade-Feldman M Baniyash M New insights into chronic inflammation-induced immunosuppression Semin Cancer Biol 2012 22 307 318 10.1016/j.semcancer.2012.02.008 22387003
Kanterman J, Sade-Feldman M, Baniyash M (2012) New insights into chronic inflammation-induced immunosuppression. Semin Cancer Biol 22:307–318. 10.1016/j.semcancer.2012.02.00822387003 10.1016/j.semcancer.2012.02.008
Kishi S Functional aging and gradual senescence in zebrafish Ann N Y Acad Sci 2004 1019 521 526 10.1196/annals.1297.097 15247079
Kishi S (2004) Functional aging and gradual senescence in zebrafish. Ann N Y Acad Sci 1019:521–526. 10.1196/annals.1297.09715247079 10.1196/annals.1297.097
Kleefeldt F Bömmel H Broede B Thomsen M Pfeiffer V Wörsdörfer P Karnati S Wagner N Rueckschloss U Ergun S Aging-related carcinoembryonic antigen-related cell adhesion molecule 1 signaling promotes vascular dysfunction Aging Cell 2019 18 e13025 10.1111/acel.13025 31389127
Kleefeldt F, Bömmel H, Broede B, Thomsen M, Pfeiffer V, Wörsdörfer P, Karnati S, Wagner N, Rueckschloss U, Ergun S (2019) Aging-related carcinoembryonic antigen-related cell adhesion molecule 1 signaling promotes vascular dysfunction. Aging Cell 18:e13025. 10.1111/acel.1302531389127 10.1111/acel.13025
Kojima Y Volkmer JP McKenna K Civelek M Lusis AJ Miller CL Direnzo D Nanda V Ye J Connolly AJ Schadt EE Quertermous T Betancur P Maegdefessel L Matic LP Hedin U Weissman IL Leeper NJ CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis Nature 2016 536 86 90 10.1038/nature18935 27437576
Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ (2016) CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536:86–90. 10.1038/nature1893527437576 10.1038/nature18935
Krishnamurthy J Torrice C Ramsey MR Kovalev GI Al-Regaiey K Su L Sharpless NE Ink4a/Arf expression is a biomarker of aging J Clin Invest 2004 114 1299 1307 10.1172/JCI22475 15520862
Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299–1307. 10.1172/JCI2247515520862 10.1172/JCI22475
Krizhanovsky V Yon M Dickins RA Hearn S Simon J Miething C Yee H Zender L Lowe SW Senescence of activated stellate cells limits liver fibrosis Cell 2008 134 657 667 10.1016/j.cell.2008.06.049 18724938
Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134:657–667. 10.1016/j.cell.2008.06.04918724938 10.1016/j.cell.2008.06.049
Krtolica A Parrinello S Lockett S Desprez PY Campisi J Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging Proc Natl Acad Sci U S A 2001 98 12072 12077 10.1073/pnas.211053698 11593017
Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98:12072–12077. 10.1073/pnas.21105369811593017 10.1073/pnas.211053698
Krzystyniak A Wesierska M Petrazzo G Gadecka A Dudkowska M Bielak-Zmijewska A Mosieniak G Figiel I Wlodarczyk J Sikora E Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile Aging 2022 14 572 595 10.18632/aging.203835 35042834
Krzystyniak A, Wesierska M, Petrazzo G, Gadecka A, Dudkowska M, Bielak-Zmijewska A, Mosieniak G, Figiel I, Wlodarczyk J, Sikora E (2022) Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile. Aging 14:572–595. 10.18632/aging.20383535042834 10.18632/aging.203835
Kuespert K Pils S Hauck CR CEACAMs: their role in physiology and pathophysiology Curr Opin Cell Biol 2006 18 565 571 10.1016/j.ceb.2006.08.008 16919437
Kuespert K, Pils S, Hauck CR (2006) CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 18:565–571. 10.1016/j.ceb.2006.08.00816919437 10.1016/j.ceb.2006.08.008
Kumazaki T Robetorye RS Robetorye SC Smith JR Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area Exp Cell Res 1991 195 13 19 10.1016/0014-4827(91)90494-f 2055262
Kumazaki T, Robetorye RS, Robetorye SC, Smith JR (1991) Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area. Exp Cell Res 195:13–19. 10.1016/0014-4827(91)90494-f2055262 10.1016/0014-4827(91)90494-f
Kumazaki T Kobayashi M Mitsui Y Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts Exp Cell Res 1993 205 396 402 10.1006/excr.1993.1103 8482345
Kumazaki T, Kobayashi M, Mitsui Y (1993) Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exp Cell Res 205:396–402. 10.1006/excr.1993.11038482345 10.1006/excr.1993.1103
Lee N Llano M Carretero M Ishitani A Navarro F Lopez-Botet M Geraghty DE HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A Proc Natl Acad Sci U S A 1998 95 5199 5204 10.1073/pnas.95.9.5199 9560253
Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95:5199–5204. 10.1073/pnas.95.9.51999560253 10.1073/pnas.95.9.5199
Lee BH Park SY Kang KB Park RW Kim IS NF-κB activates fibronectin gene expression in rat hepatocytes Biochem Biophys Res Commun 2002 297 1218 1224 10.1016/s0006-291x(02)02356-2 12372417
Lee BH, Park SY, Kang KB, Park RW, Kim IS (2002) NF-κB activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun 297:1218–1224. 10.1016/s0006-291x(02)02356-212372417 10.1016/s0006-291x(02)02356-2
Lee DH Imran M Choi JH Park YJ Kim YH Min S Park TJ Choi YW CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents Mol Oncol 2024 18 216 232 10.1002/1878-0261.13541 37854019
Lee DH, Imran M, Choi JH, Park YJ, Kim YH, Min S, Park TJ, Choi YW (2024) CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents. Mol Oncol 18:216–232. 10.1002/1878-0261.1354137854019 10.1002/1878-0261.13541
Li MO Wan YY Sanjabi S Robertson AK Flavell RA Transforming growth factor-β regulation of immune responses Annu Rev Immunol 2006 24 99 146 10.1146/annurev.immunol.24.021605.090737 16551245
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146. 10.1146/annurev.immunol.24.021605.09073716551245 10.1146/annurev.immunol.24.021605.090737
Li R Mukherjee MB Lin J Coordinated regulation of myeloid-derived suppressor cells by cytokines and chemokines Cancers (basel) 2022 14 1236 10.3390/cancers14051236 35267547
Li R, Mukherjee MB, Lin J (2022) Coordinated regulation of myeloid-derived suppressor cells by cytokines and chemokines. Cancers (basel) 14:1236. 10.3390/cancers1405123635267547 10.3390/cancers14051236
Lian J Yue Y Yu W Zhang Y Immunosenescence: a key player in cancer development J Hematol Oncol 2020 13 151 10.1186/s13045-020-00986-z 33168037
Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol 13:151. 10.1186/s13045-020-00986-z33168037 10.1186/s13045-020-00986-z
Liu H Yang J Zhang J Zhang P Zhang M Yang C Liu L Huang C Wang W Zhai Y Yang J Molecular regulatory mechanism of LILRB4 in the immune response Cent Eur J Immunol 2023 48 43 47 10.5114/ceji.2023.125238 37206591
Liu H, Yang J, Zhang J, Zhang P, Zhang M, Yang C, Liu L, Huang C, Wang W, Zhai Y, Yang J (2023) Molecular regulatory mechanism of LILRB4 in the immune response. Cent Eur J Immunol 48:43–47. 10.5114/ceji.2023.12523837206591 10.5114/ceji.2023.125238
Ljubic M Prasnikar E Perdih A Borisek J All-atom simulations reveal the intricacies of signal transduction upon binding of the HLA-E ligand to the transmembrane inhibitory CD94/NKG2A receptor J Chem Inf Model 2023 63 3486 3499 10.1021/acs.jcim.3c00249 37207294
Ljubic M, Prasnikar E, Perdih A, Borisek J (2023) All-atom simulations reveal the intricacies of signal transduction upon binding of the HLA-E ligand to the transmembrane inhibitory CD94/NKG2A receptor. J Chem Inf Model 63:3486–3499. 10.1021/acs.jcim.3c0024937207294 10.1021/acs.jcim.3c00249
Logtenberg MEW Scheeren FA Schumacher TN The CD47-SIRPα immune checkpoint Immunity 2020 52 742 752 10.1016/j.immuni.2020.04.011 32433947
Logtenberg MEW, Scheeren FA, Schumacher TN (2020) The CD47-SIRPα immune checkpoint. Immunity 52:742–752. 10.1016/j.immuni.2020.04.01132433947 10.1016/j.immuni.2020.04.011
Lu F Zhao Y Pang Y Ji M Sun Y Wang H Zou J Wang Y Li G Sun T Li J Ma D Ye J Ji C NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma Cancer Lett 2021 497 178 189 10.1016/j.canlet.2020.10.024 33091534
Lu F, Zhao Y, Pang Y, Ji M, Sun Y, Wang H, Zou J, Wang Y, Li G, Sun T, Li J, Ma D, Ye J, Ji C (2021) NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma. Cancer Lett 497:178–189. 10.1016/j.canlet.2020.10.02433091534 10.1016/j.canlet.2020.10.024
Lyu G Guan Y Zhang C Zong L Sun L Huang X Huang L Zhang L Tian XL Zhou Z Tao W TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging Nat Commun 2018 9 2560 10.1038/s41467-018-04994-z 29967491
Lyu G, Guan Y, Zhang C, Zong L, Sun L, Huang X, Huang L, Zhang L, Tian XL, Zhou Z, Tao W (2018) TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging. Nat Commun 9:2560. 10.1038/s41467-018-04994-z29967491 10.1038/s41467-018-04994-z
Mantovani A Sica A Sozzani S Allavena P Vecchi A Locati M The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 2004 25 677 686 10.1016/j.it.2004.09.015 15530839
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686. 10.1016/j.it.2004.09.01515530839 10.1016/j.it.2004.09.015
Marin I Boix O Garcia-Garijo A Sirois I Caballe A Zarzuela E Ruano I Attolini CS Prats N Lopez-Dominguez JA Kovatcheva M Garralda E Munoz J Caron E Abad M Gros A Pietrocola F Serrano M Cellular senescence is immunogenic and promotes antitumor immunity Cancer Discov 2023 13 410 431 10.1158/2159-8290.CD-22-0523 36302218
Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, Ruano I, Attolini CS, Prats N, Lopez-Dominguez JA, Kovatcheva M, Garralda E, Munoz J, Caron E, Abad M, Gros A, Pietrocola F, Serrano M (2023) Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discov 13:410–431. 10.1158/2159-8290.CD-22-052336302218 10.1158/2159-8290.CD-22-0523
Martinez-Zamudio RI Dewald HK Vasilopoulos T Gittens-Williams L Fitzgerald-Bocarsly P Herbig U Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans Aging Cell 2021 20 e13344 10.1111/acel.13344 33939265
Martinez-Zamudio RI, Dewald HK, Vasilopoulos T, Gittens-Williams L, Fitzgerald-Bocarsly P, Herbig U (2021) Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell 20:e13344. 10.1111/acel.1334433939265 10.1111/acel.13344
Matsuda S Revandkar A Dubash TD Ravi A Wittner BS Lin M Morris R Burr R Guo H Seeger K Szabolcs A Che D Nieman L Getz GA Ting DT Lawrence MS Gainor J Haber DA Maheswaran S TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state Cell Rep 2023 42 112129 10.1016/j.celrep.2023.112129 36821441
Matsuda S, Revandkar A, Dubash TD, Ravi A, Wittner BS, Lin M, Morris R, Burr R, Guo H, Seeger K, Szabolcs A, Che D, Nieman L, Getz GA, Ting DT, Lawrence MS, Gainor J, Haber DA, Maheswaran S (2023) TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Rep 42:112129. 10.1016/j.celrep.2023.11212936821441 10.1016/j.celrep.2023.112129
Mehdizadeh M Aguilar M Thorin E Ferbeyre G Nattel S The role of cellular senescence in cardiac disease: basic biology and clinical relevance Nat Rev Cardiol 2022 19 250 264 10.1038/s41569-021-00624-2 34667279
Mehdizadeh M, Aguilar M, Thorin E, Ferbeyre G, Nattel S (2022) The role of cellular senescence in cardiac disease: basic biology and clinical relevance. Nat Rev Cardiol 19:250–264. 10.1038/s41569-021-00624-234667279 10.1038/s41569-021-00624-2
Mitchell A Malmgren L Bartosch P McGuigan FE Akesson KE Pro-inflammatory proteins associated with frailty and its progression-a longitudinal study in community-dwelling women J Bone Miner Res 2023 38 1076 1091 10.1002/jbmr.4861 37254268
Mitchell A, Malmgren L, Bartosch P, McGuigan FE, Akesson KE (2023) Pro-inflammatory proteins associated with frailty and its progression-a longitudinal study in community-dwelling women. J Bone Miner Res 38:1076–1091. 10.1002/jbmr.486137254268 10.1002/jbmr.4861
Mizuno R Sugiura D Shimizu K Maruhashi T Watada M Okazaki IM Okazaki T PD-1 primarily targets TCR signal in the inhibition of functional T cell activation Front Immunol 2019 10 630 10.3389/fimmu.2019.00630 31001256
Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki IM, Okazaki T (2019) PD-1 primarily targets TCR signal in the inhibition of functional T cell activation. Front Immunol 10:630. 10.3389/fimmu.2019.0063031001256 10.3389/fimmu.2019.00630
Mylonas A O’Loghlen A Cellular senescence and ageing: mechanisms and interventions Front Aging 2022 3 866718 10.3389/fragi.2022.866718 35821824
Mylonas A, O’Loghlen A (2022) Cellular senescence and ageing: mechanisms and interventions. Front Aging 3:866718. 10.3389/fragi.2022.86671835821824 10.3389/fragi.2022.866718
Nakayama M Akiba H Takeda K Kojima Y Hashiguchi M Azuma M Yagita H Okumura K Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation Blood 2009 113 3821 3830 10.1182/blood-2008-10-185884 19224762
Nakayama M, Akiba H, Takeda K, Kojima Y, Hashiguchi M, Azuma M, Yagita H, Okumura K (2009) Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113:3821–3830. 10.1182/blood-2008-10-18588419224762 10.1182/blood-2008-10-185884
Nam S Lee A Lim J Lim JS Analysis of the expression and regulation of PD-1 protein on the surface of myeloid-derived suppressor cells (MDSCs) Biomol Ther (seoul) 2019 27 63 70 10.4062/biomolther.2018.201 30521746
Nam S, Lee A, Lim J, Lim JS (2019) Analysis of the expression and regulation of PD-1 protein on the surface of myeloid-derived suppressor cells (MDSCs). Biomol Ther (seoul) 27:63–70. 10.4062/biomolther.2018.20130521746 10.4062/biomolther.2018.201
Nawas AF Solmonson A Gao B DeBerardinis RJ Minna JD Conacci-Sorrell M Mendelson CR IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells Cell Commun Signal 2023 21 331 10.1186/s12964-023-01348-1 37985999
Nawas AF, Solmonson A, Gao B, DeBerardinis RJ, Minna JD, Conacci-Sorrell M, Mendelson CR (2023) IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells. Cell Commun Signal 21:331. 10.1186/s12964-023-01348-137985999 10.1186/s12964-023-01348-1
Nelson G Wordsworth J Wang C Jurk D Lawless C Martin-Ruiz C von Zglinicki T A senescent cell bystander effect: senescence-induced senescence Aging Cell 2012 11 345 349 10.1111/j.1474-9726.2012.00795.x 22321662
Nelson G, Wordsworth J, Wang C, Jurk D, Lawless C, Martin-Ruiz C, von Zglinicki T (2012) A senescent cell bystander effect: senescence-induced senescence. Aging Cell 11:345–349. 10.1111/j.1474-9726.2012.00795.x22321662 10.1111/j.1474-9726.2012.00795.x
Nelson G Kucheryavenko O Wordsworth J von Zglinicki T The senescent bystander effect is caused by ROS-activated NF-κB signalling Mech Ageing Dev 2018 170 30 36 10.1016/j.mad.2017.08.005 28837845
Nelson G, Kucheryavenko O, Wordsworth J, von Zglinicki T (2018) The senescent bystander effect is caused by ROS-activated NF-κB signalling. Mech Ageing Dev 170:30–36. 10.1016/j.mad.2017.08.00528837845 10.1016/j.mad.2017.08.005
Nunez SY Ziblat A Secchiari F Torres NI Sierra JM Raffo Iraolagoitia XL Araya RE Domaica CI Fuertes MB Zwirner NW Human M2 macrophages limit NK cell effector functions through secretion of TGF-β and engagement of CD85j J Immunol 2018 200 1008 1015 10.4049/jimmunol.1700737 29282306
Nunez SY, Ziblat A, Secchiari F, Torres NI, Sierra JM, Raffo Iraolagoitia XL, Araya RE, Domaica CI, Fuertes MB, Zwirner NW (2018) Human M2 macrophages limit NK cell effector functions through secretion of TGF-β and engagement of CD85j. J Immunol 200:1008–1015. 10.4049/jimmunol.170073729282306 10.4049/jimmunol.1700737
Ogrodnik M Miwa S Tchkonia T Tiniakos D Wilson CL Lahat A Day CP Burt A Palmer A Anstee QM Grellscheid SN Hoeijmakers JHJ Barnhoorn S Mann DA Bird TG Vermeij WP Kirkland JL Passos JF von Zglinicki T Jurk D Cellular senescence drives age-dependent hepatic steatosis Nat Commun 2017 8 15691 10.1038/ncomms15691 28608850
Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, Day CP, Burt A, Palmer A, Anstee QM, Grellscheid SN, Hoeijmakers JHJ, Barnhoorn S, Mann DA, Bird TG, Vermeij WP, Kirkland JL, Passos JF, von Zglinicki T, Jurk D (2017) Cellular senescence drives age-dependent hepatic steatosis. Nat Commun 8:15691. 10.1038/ncomms1569128608850 10.1038/ncomms15691
Ohta A A metabolic immune checkpoint: adenosine in tumor microenvironment Front Immunol 2016 7 109 10.3389/fimmu.2016.00109 27066002
Ohta A (2016) A metabolic immune checkpoint: adenosine in tumor microenvironment. Front Immunol 7:109. 10.3389/fimmu.2016.0010927066002 10.3389/fimmu.2016.00109
Okazaki T Maeda A Nishimura H Kurosaki T Honjo T PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine Proc Natl Acad Sci U S A 2001 98 13866 13871 10.1073/pnas.231486598 11698646
Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 98:13866–13871. 10.1073/pnas.23148659811698646 10.1073/pnas.231486598
Onorati A Havas AP Lin B Rajagopal J Sen P Adams PD Dou Z Upregulation of PD-L1 in senescence and aging Mol Cell Biol 2022 42 e0017122 10.1128/mcb.00171-22 36154662
Onorati A, Havas AP, Lin B, Rajagopal J, Sen P, Adams PD, Dou Z (2022) Upregulation of PD-L1 in senescence and aging. Mol Cell Biol 42:e0017122. 10.1128/mcb.00171-2236154662 10.1128/mcb.00171-22
Osorio JM Espinoza-Perez C Rimassa-Tare C Machuca V Bustos JO Vallejos M Vargas H Diaz-Araya G Senescent cardiac fibroblasts: a key role in cardiac fibrosis Biochim Biophys Acta Mol Basis Dis 2023 1869 166642 10.1016/j.bbadis.2023.166642 36669578
Osorio JM, Espinoza-Perez C, Rimassa-Tare C, Machuca V, Bustos JO, Vallejos M, Vargas H, Diaz-Araya G (2023) Senescent cardiac fibroblasts: a key role in cardiac fibrosis. Biochim Biophys Acta Mol Basis Dis 1869:166642. 10.1016/j.bbadis.2023.16664236669578 10.1016/j.bbadis.2023.166642
Ouyang W Rutz S Crellin NK Valdez PA Hymowitz SG Regulation and functions of the IL-10 family of cytokines in inflammation and disease Annu Rev Immunol 2011 29 71 109 10.1146/annurev-immunol-031210-101312 21166540
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71–109. 10.1146/annurev-immunol-031210-10131221166540 10.1146/annurev-immunol-031210-101312
Ovadya Y Landsberger T Leins H Vadai E Gal H Biran A Yosef R Sagiv A Agrawal A Shapira A Windheim J Tsoory M Schirmbeck R Amit I Geiger H Krizhanovsky V Impaired immune surveillance accelerates accumulation of senescent cells and aging Nat Commun 2018 9 5435 10.1038/s41467-018-07825-3 30575733
Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A, Windheim J, Tsoory M, Schirmbeck R, Amit I, Geiger H, Krizhanovsky V (2018) Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat Commun 9:5435. 10.1038/s41467-018-07825-330575733 10.1038/s41467-018-07825-3
Paavola KJ Roda JM Lin VY Chen P O’Hollaren KP Ventura R Crawley SC Li B Chen HH Malmersjö S Sharkov NA Horner G Guo W Kutach AK Mondal K Zhang Z Lichtman JS Song C Rivera LB Liu W Luo J Wang Y Solloway MJ Allan BB Kekatpure A Starck SR Haldankar R Fan B Chu C Tang J Molgora M Colonna M Kaplan DD Hsu JY The fibronectin-ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells Cancer Immunol Res 2021 9 1283 1297 10.1158/2326-6066.CIR-21-0240 34426457
Paavola KJ, Roda JM, Lin VY, Chen P, O’Hollaren KP, Ventura R, Crawley SC, Li B, Chen HH, Malmersjö S, Sharkov NA, Horner G, Guo W, Kutach AK, Mondal K, Zhang Z, Lichtman JS, Song C, Rivera LB, Liu W, Luo J, Wang Y, Solloway MJ, Allan BB, Kekatpure A, Starck SR, Haldankar R, Fan B, Chu C, Tang J, Molgora M, Colonna M, Kaplan DD, Hsu JY (2021) The fibronectin-ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells. Cancer Immunol Res 9:1283–1297. 10.1158/2326-6066.CIR-21-024034426457 10.1158/2326-6066.CIR-21-0240
Park BV Freeman ZT Ghasemzadeh A Chattergoon MA Rutebemberwa A Steigner J Winter ME Huynh TV Sebald SM Lee SJ Pan F Pardoll DM Cox AL TGFβ1-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer Cancer Discov 2016 6 1366 1381 10.1158/2159-8290.CD-15-1347 27683557
Park BV, Freeman ZT, Ghasemzadeh A, Chattergoon MA, Rutebemberwa A, Steigner J, Winter ME, Huynh TV, Sebald SM, Lee SJ, Pan F, Pardoll DM, Cox AL (2016) TGFβ1-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer. Cancer Discov 6:1366–1381. 10.1158/2159-8290.CD-15-134727683557 10.1158/2159-8290.CD-15-1347
Paul S Lal G The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy Front Immunol 2017 8 1124 10.3389/fimmu.2017.01124 28955340
Paul S, Lal G (2017) The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol 8:1124. 10.3389/fimmu.2017.0112428955340 10.3389/fimmu.2017.01124
Pei L Liu Y Liu L Gao S Gao X Feng Y Sun Z Zhang Y Wang C Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers Mol Cancer 2023 22 29 10.1186/s12943-023-01731-z 36759842
Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y, Sun Z, Zhang Y, Wang C (2023) Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers. Mol Cancer 22:29. 10.1186/s12943-023-01731-z36759842 10.1186/s12943-023-01731-z
Pereira BI Devine OP Vukmanovic-Stejic M Chambers ES Subramanian P Patel N Virasami A Sebire NJ Kinsler V Valdovinos A LeSaux CJ Passos JF Antoniou A Rustin MHA Campisi J Akbar AN Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition Nat Commun 2019 10 2387 10.1038/s41467-019-10335-5 31160572
Pereira BI, Devine OP, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler V, Valdovinos A, LeSaux CJ, Passos JF, Antoniou A, Rustin MHA, Campisi J, Akbar AN (2019) Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nat Commun 10:2387. 10.1038/s41467-019-10335-531160572 10.1038/s41467-019-10335-5
Polverino F Mirra D Yang CX Esposito R Spaziano G Rojas-Quintero J Sgambato M Piegari E Cozzolino A Cione E Gallelli L Capuozzo A Santoriello C Berrino L de-Torres JP HackettPolverino TLM D’Agostiono B Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer Sci Rep 2022 12 22402 10.1038/s41598-022-26650-9 36575294
Polverino F, Mirra D, Yang CX, Esposito R, Spaziano G, Rojas-Quintero J, Sgambato M, Piegari E, Cozzolino A, Cione E, Gallelli L, Capuozzo A, Santoriello C, Berrino L, de-Torres JP, HackettPolverino TLM, D’Agostiono B (2022) Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer. Sci Rep 12:22402. 10.1038/s41598-022-26650-936575294 10.1038/s41598-022-26650-9
Qwarnström EE Ostberg CO Turk GL Richardson CA Bomsztyk K Fibronectin attachment activates the NF-κB p50/p65 heterodimer in fibroblasts and smooth muscle cells J Biol Chem 1994 269 30765 30768 10.1016/S0021-9258(18)47345-0 7983003
Qwarnström EE, Ostberg CO, Turk GL, Richardson CA, Bomsztyk K (1994) Fibronectin attachment activates the NF-κB p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem 269:30765–307687983003 10.1016/S0021-9258(18)47345-0
Ralainirina N Poli A Michel T Poos L Andres E Hentges F Zimmer J Control of NK cell functions by CD4+CD25+ regulatory T cells J Leukoc Biol 2007 81 144 153 10.1189/jlb.0606409 16959895
Ralainirina N, Poli A, Michel T, Poos L, Andres E, Hentges F, Zimmer J (2007) Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 81:144–153. 10.1189/jlb.060640916959895 10.1189/jlb.0606409
Rapisarda V Borghesan M Miguela V Encheva V Snijders AP Lujambio A O’Loghlen A Integrin β3 regulates cellular senescence by activating the TGF-β pathway Cell Rep 2017 18 2480 2493 10.1016/j.celrep.2017.02.012 28273461
Rapisarda V, Borghesan M, Miguela V, Encheva V, Snijders AP, Lujambio A, O’Loghlen A (2017) Integrin β3 regulates cellular senescence by activating the TGF-β pathway. Cell Rep 18:2480–2493. 10.1016/j.celrep.2017.02.01228273461 10.1016/j.celrep.2017.02.012
Ravetch JV Lanier LL Immune inhibitory receptors Science 2000 290 84 89 10.1126/science.290.5489.84 11021804
Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84–89. 10.1126/science.290.5489.8411021804 10.1126/science.290.5489.84
Redondo-Garcia S Barritt C Papagregoriou C Yeboah M Frendeus B Cragg MS Roghanian A Human leukocyte immunoglobulin-like receptors in health and disease Front Immunol 2023 14 1282874 10.3389/fimmu.2023.1282874 38022598
Redondo-Garcia S, Barritt C, Papagregoriou C, Yeboah M, Frendeus B, Cragg MS, Roghanian A (2023) Human leukocyte immunoglobulin-like receptors in health and disease. Front Immunol 14:1282874. 10.3389/fimmu.2023.128287438022598 10.3389/fimmu.2023.1282874
Ren LL Miao H Wang YN Liu F Li P Zhao YY TGF-β as a master regulator of aging-associated tissue fibrosis Aging Dis 2023 14 1633 10.14336/AD.2023.0222 37196129
Ren LL, Miao H, Wang YN, Liu F, Li P, Zhao YY (2023) TGF-β as a master regulator of aging-associated tissue fibrosis. Aging Dis 14:163337196129 10.14336/AD.2023.0222
Roberts DD Isenberg JS CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes Am J Physiol Cell Physiol 2021 321 C201 C213 10.1152/ajpcell.00175.2021 34106789
Roberts DD, Isenberg JS (2021) CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes. Am J Physiol Cell Physiol 321:C201–C213. 10.1152/ajpcell.00175.202134106789 10.1152/ajpcell.00175.2021
Roberts CJ Birkenmeier TM McQuillan JJ Akiyama SK Yamada SS Chen WT Yamada KM McDonald JA Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts J Biol Chem 1988 263 4586 4592 10.1016/S0021-9258(18)68822-2 2965146
Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA (1988) Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 263:4586–45922965146 10.1016/S0021-9258(18)68822-2
Rodier F Coppe JP Patil CK Hoeijmakers WA Munoz DP Raza SR Freund A Campeau E Davalos AR Campisi J Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat Cell Biol 2009 11 973 979 10.1038/ncb1909 19597488
Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11:973–979. 10.1038/ncb190919597488 10.1038/ncb1909
Rong QX Wang F Guo ZX Hu Y An SN Luo M Zhang H Wu SC Huang HQ Fu LW GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma Mol Cancer 2021 20 80 10.1186/s12943-021-01374-y 34051805
Rong QX, Wang F, Guo ZX, Hu Y, An SN, Luo M, Zhang H, Wu SC, Huang HQ, Fu LW (2021) GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma. Mol Cancer 20:80. 10.1186/s12943-021-01374-y34051805 10.1186/s12943-021-01374-y
Ruhland MK Loza AJ Capietto AH Luo X Knolhoff BL Flanagan KC Belt BA Alspach E Leahy K Luo J Schaffer A Edwards JR Longmore G Faccio R DeNardo DG Stewart SA Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis Nat Commun 2016 7 11762 10.1038/ncomms11762 27272654
Ruhland MK, Loza AJ, Capietto AH, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J, Schaffer A, Edwards JR, Longmore G, Faccio R, DeNardo DG, Stewart SA (2016) Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun 7:11762. 10.1038/ncomms1176227272654 10.1038/ncomms11762
Sagiv A Burton DG Moshayev Z Vadai E Wensveen F Ben-Dor S Golani O Polic B Krizhanovsky V NKG2D ligands mediate immunosurveillance of senescent cells Aging 2016 8 328 344 10.18632/aging.100897 26878797
Sagiv A, Burton DG, Moshayev Z, Vadai E, Wensveen F, Ben-Dor S, Golani O, Polic B, Krizhanovsky V (2016) NKG2D ligands mediate immunosurveillance of senescent cells. Aging 8:328–344. 10.18632/aging.10089726878797 10.18632/aging.100897
Saini P Adeniji OS Abdel-Mohsen M Inhibitory siglec-sialic acid interactions in balancing immunological activation and tolerance during viral infections EBioMedicine 2022 86 104354 10.1016/j.ebiom.2022.104354 36371982
Saini P, Adeniji OS, Abdel-Mohsen M (2022) Inhibitory siglec-sialic acid interactions in balancing immunological activation and tolerance during viral infections. EBioMedicine 86:104354. 10.1016/j.ebiom.2022.10435436371982 10.1016/j.ebiom.2022.104354
Salminen A Activation of immunosuppressive network in the aging process Ageing Res Rev 2020 57 100998 10.1016/j.arr.2019.100998 31838128
Salminen A (2020) Activation of immunosuppressive network in the aging process. Ageing Res Rev 57:100998. 10.1016/j.arr.2019.10099831838128 10.1016/j.arr.2019.100998
Salminen A Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions J Mol Med (berl) 2021 99 1553 1569 10.1007/s00109-021-02123-w 34432073
Salminen A (2021) Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. J Mol Med (berl) 99:1553–1569. 10.1007/s00109-021-02123-w34432073 10.1007/s00109-021-02123-w
Salminen A Clinical perspectives on the age-related increase of immunosuppressive activity J Mol Med (berl) 2022 100 697 712 10.1007/s00109-022-02193-4 35384505
Salminen A (2022) Clinical perspectives on the age-related increase of immunosuppressive activity. J Mol Med (berl) 100:697–712. 10.1007/s00109-022-02193-435384505 10.1007/s00109-022-02193-4
Salminen A The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases J Mol Med (berl) 2024 102 733 750 10.1007/s00109-024-02444-6 38600305
Salminen A (2024) The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases. J Mol Med (berl) 102:733–750. 10.1007/s00109-024-02444-638600305 10.1007/s00109-024-02444-6
Salminen A Huuskonen J Ojala J Kauppinen A Kaarniranta K Suuronen T Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflamm-aging Ageing Res Rev 2008 7 83 105 10.1016/j.arr.2007.09.002 17964225
Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2008a) Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7:83–105. 10.1016/j.arr.2007.09.00217964225 10.1016/j.arr.2007.09.002
Salminen A Paimela T Suuronen T Kaarniranta K Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90 Immunol Lett 2008 117 9 15 10.1016/j.imlet.2007.12.017 18282612
Salminen A, Paimela T, Suuronen T, Kaarniranta K (2008b) Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90. Immunol Lett 117:9–15. 10.1016/j.imlet.2007.12.01718282612 10.1016/j.imlet.2007.12.017
Salminen A Kaarniranta K Kauppinen A Exosomal vesicles enhance immunosuppression in chronic inflammation: Impact in cellular senescence and the aging process Cell Signal 2020 75 109771 10.1016/j.cellsig.2020.109771 32896608
Salminen A, Kaarniranta K, Kauppinen A (2020) Exosomal vesicles enhance immunosuppression in chronic inflammation: Impact in cellular senescence and the aging process. Cell Signal 75:109771. 10.1016/j.cellsig.2020.10977132896608 10.1016/j.cellsig.2020.109771
Salzer MC Lafzi A Berenguer-Llergo A Youssif C Castellanos A Solanas G Peixoto FO Stephan-Otto Attolini C Prats N Aguilera M Martin-Caballero J Heyn H Benitah SA Identity noise and adipogenic traits characterize dermal fibroblast aging Cell 2018 175 1575 1590.e22 10.1016/j.cell.2018.10.012 30415840
Salzer MC, Lafzi A, Berenguer-Llergo A, Youssif C, Castellanos A, Solanas G, Peixoto FO, Stephan-Otto Attolini C, Prats N, Aguilera M, Martin-Caballero J, Heyn H, Benitah SA (2018) Identity noise and adipogenic traits characterize dermal fibroblast aging. Cell 175:1575-1590.e22. 10.1016/j.cell.2018.10.01230415840 10.1016/j.cell.2018.10.012
Santoro A Bientinesi E Monti D Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res Rev 2021 71 101422 10.1016/j.arr.2021.101422 34391943
Santoro A, Bientinesi E, Monti D (2021) Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? Ageing Res Rev 71:101422. 10.1016/j.arr.2021.10142234391943 10.1016/j.arr.2021.101422
Sappino AP Buser R Seguin Q Fernet M Lesne L Gumy-Pause F Reith W Favaudon V Mandriota SJ The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage Oncogenesis 2012 1 e7 10.1038/oncsis.2012.7 23552604
Sappino AP, Buser R, Seguin Q, Fernet M, Lesne L, Gumy-Pause F, Reith W, Favaudon V, Mandriota SJ (2012) The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis 1:e7. 10.1038/oncsis.2012.723552604 10.1038/oncsis.2012.7
Saresella M Calabrese E Marventano I Piancone F Gatti A Farina E Alberoni M Clerici M A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer’s disease Neurobiol Aging 2012 33 624.e11 22 10.1016/j.neurobiolaging.2011.03.004 21514692
Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Farina E, Alberoni M, Clerici M (2012) A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer’s disease. Neurobiol Aging 33:624.e11–22. 10.1016/j.neurobiolaging.2011.03.00421514692 10.1016/j.neurobiolaging.2011.03.004
Sauer N Janicka N Szlasa W Skinderowicz B Kolodzinska K Dwernicka W Oslizlo M Kulbacka J Novickij V Karlowicz-Bodalska K TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors Cancer Immunol Immunother 2023 72 3405 3425 10.1007/s00262-023-03516-1 37567938
Sauer N, Janicka N, Szlasa W, Skinderowicz B, Kolodzinska K, Dwernicka W, Oslizlo M, Kulbacka J, Novickij V, Karlowicz-Bodalska K (2023) TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors. Cancer Immunol Immunother 72:3405–3425. 10.1007/s00262-023-03516-137567938 10.1007/s00262-023-03516-1
Schafer MJ White TA Iijima K Haak AJ Ligresti G Atkinson EJ Oberg AL Birch J Salmonowicz H Zhu Y Mazula DL Brooks RW Fuhrmann-Stroissnigg H Pirtskhalava T Prakash YS Tchkonia T Robbins PD Aubry MC Passos JF Kirkland JL Tschumperlin DJ Kita H LeBrasseur NK Cellular senescence mediates fibrotic pulmonary disease Nat Commun 2017 8 14532 10.1038/ncomms14532 28230051
Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, Oberg AL, Birch J, Salmonowicz H, Zhu Y, Mazula DL, Brooks RW, Fuhrmann-Stroissnigg H, Pirtskhalava T, Prakash YS, Tchkonia T, Robbins PD, Aubry MC, Passos JF, Kirkland JL, Tschumperlin DJ, Kita H, LeBrasseur NK (2017) Cellular senescence mediates fibrotic pulmonary disease. Nat Commun 8:14532. 10.1038/ncomms1453228230051 10.1038/ncomms14532
Schloesser D, Lindenthal L, Sauer J, Chung KJ, Chavakis T, Griesser E, Baskaran P, Maier-Habelsberger U, Fundel-Clemens K, Schlotthauer I, Watson CK, Swee LK, Igney F, Park JE, Huber-Lang MS, Thomas MJ, El Kasmi KC, Murray PJ Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis J Cell Biol 2023 222 e202207097 10.1083/jcb.202207097 36459066
Schloesser D, Lindenthal L, Sauer J, Chung KJ, Chavakis T, Griesser E, Baskaran P, Maier-Habelsberger U, Fundel-Clemens K, Schlotthauer I, Watson CK, Swee LK, Igney F, Park JE, Huber-Lang MS, Thomas MJ, El Kasmi KC, Murray PJ (2023) Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis. J Cell Biol 222:e202207097. 10.1083/jcb.20220709736459066 10.1083/jcb.202207097
Seki M Oomizu S Sakata KM Sakata A Arikawa T Watanabe K Ito K Takeshita K Niki T Saita N Nishi N Yamauchi A Katoh S Matsukawa A Kuchroo V Hirashima M Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Clin Immunol 2008 127 78 88 10.1016/j.clim.2008.01.006 18282810
Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N, Nishi N, Yamauchi A, Katoh S, Matsukawa A, Kuchroo V, Hirashima M (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127:78–88. 10.1016/j.clim.2008.01.00618282810 10.1016/j.clim.2008.01.006
Shah K Al-Haidari A Sun J Kazi JU T cell receptor (TCR) signaling in health and disease Signal Transduct Target Ther 2021 6 412 10.1038/s41392-021-00823-w 34897277
Shah K, Al-Haidari A, Sun J, Kazi JU (2021) T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther 6:412. 10.1038/s41392-021-00823-w34897277 10.1038/s41392-021-00823-w
Sharma N Atolagbe OT Ge Z Allison JP LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy J Exp Med 2021 218 e20201811 10.1084/jem.20201811 33974041
Sharma N, Atolagbe OT, Ge Z, Allison JP (2021) LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med 218:e20201811. 10.1084/jem.2020181133974041 10.1084/jem.20201811
Shekari N Shanehbandi D Kazemi T Zarredar H Baradaran B Jalali SA VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy Cancer Cell Int 2023 23 265 10.1186/s12935-023-03116-0 37936192
Shekari N, Shanehbandi D, Kazemi T, Zarredar H, Baradaran B, Jalali SA (2023) VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy. Cancer Cell Int 23:265. 10.1186/s12935-023-03116-037936192 10.1186/s12935-023-03116-0
Shevitz J Jenkins CS Hatcher VB Fibronectin synthesis and degradation in human fibroblasts with aging Mech Ageing Dev 1986 35 221 232 10.1016/0047-6374(86)90125-9 3773572
Shevitz J, Jenkins CS, Hatcher VB (1986) Fibronectin synthesis and degradation in human fibroblasts with aging. Mech Ageing Dev 35:221–232. 10.1016/0047-6374(86)90125-93773572 10.1016/0047-6374(86)90125-9
Shimizu A Sawada K Kobayashi M Yamamoto M Yagi T Kinose Y Kodama M Hashimoto K Kimura T Exosomal CD47 plays an essential role in immune evasion in ovarian cancer Mol Cancer Res 2021 19 1583 1595 10.1158/1541-7786.MCR-20-0956 34016744
Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, Kodama M, Hashimoto K, Kimura T (2021) Exosomal CD47 plays an essential role in immune evasion in ovarian cancer. Mol Cancer Res 19:1583–1595. 10.1158/1541-7786.MCR-20-095634016744 10.1158/1541-7786.MCR-20-0956
Shiravand Y Khodadadi F Kashani SMA Hosseini-Fard SR Hosseini S Sadeghirad H Ladwa R O’Byrne K Kulasinghe A Immune checkpoint inhibitors in cancer therapy Curr Oncol 2022 29 3044 3060 10.3390/curroncol29050247 35621637
Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O’Byrne K, Kulasinghe A (2022) Immune checkpoint inhibitors in cancer therapy. Curr Oncol 29:3044–3060. 10.3390/curroncol2905024735621637 10.3390/curroncol29050247
Shiri AM Zhang T Bedke T Zazara DE Zhao L Lücke J Sabihi M Fazio A Zhang S Tauriello DVF Batlle E Steglich B Kempski J Agalioti T Nawrocki M Xu Y Riecken K Liebold I Brockmann L Konczalla L Bosurgi L Mercanoglu B Seeger P Küsters N Lykoudis PM Heumann A Arck PC Fehse B Busch P Grotelüschen R Mann O Izbicki JR Hackert T Flavell RA Gagliani N Giannou AD Huber S IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction J Hepatol 2024 80 634 644 10.1016/j.jhep.2023.12.015 38160941
Shiri AM, Zhang T, Bedke T, Zazara DE, Zhao L, Lücke J, Sabihi M, Fazio A, Zhang S, Tauriello DVF, Batlle E, Steglich B, Kempski J, Agalioti T, Nawrocki M, Xu Y, Riecken K, Liebold I, Brockmann L, Konczalla L, Bosurgi L, Mercanoglu B, Seeger P, Küsters N, Lykoudis PM, Heumann A, Arck PC, Fehse B, Busch P, Grotelüschen R, Mann O, Izbicki JR, Hackert T, Flavell RA, Gagliani N, Giannou AD, Huber S (2024) IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J Hepatol 80:634–644. 10.1016/j.jhep.2023.12.01538160941 10.1016/j.jhep.2023.12.015
Sikora E Bielak-Zmijewska A Mosieniak G Targeting normal and cancer senescent cells as a strategy of senotherapy Ageing Res Rev 2019 55 100941 10.1016/j.arr.2019.100941 31408714
Sikora E, Bielak-Zmijewska A, Mosieniak G (2019) Targeting normal and cancer senescent cells as a strategy of senotherapy. Ageing Res Rev 55:100941. 10.1016/j.arr.2019.10094131408714 10.1016/j.arr.2019.100941
Sikora E Bielak-Zmijewska A Mosieniak G A common signature of cellular senescence; does it exist? Ageing Res Rev 2021 71 101458 10.1016/j.arr.2021.101458 34500043
Sikora E, Bielak-Zmijewska A, Mosieniak G (2021) A common signature of cellular senescence; does it exist? Ageing Res Rev 71:101458. 10.1016/j.arr.2021.10145834500043 10.1016/j.arr.2021.101458
Singh L Muise ES Bhattacharya A Grein J Javaid S Stivers P Zhang J Qu Y Joyce-Shaikh B Loboda A Zhang C Meehl M Chiang DY Ranganath SH Rosenzweig M Brandish PE ILT3 (LILRB4) promotes the immunosuppressive function of tumor-educated human monocytic myeloid-derived suppressor cells Mol Cancer Res 2021 19 702 716 10.1158/1541-7786.MCR-20-0622 33372059
Singh L, Muise ES, Bhattacharya A, Grein J, Javaid S, Stivers P, Zhang J, Qu Y, Joyce-Shaikh B, Loboda A, Zhang C, Meehl M, Chiang DY, Ranganath SH, Rosenzweig M, Brandish PE (2021) ILT3 (LILRB4) promotes the immunosuppressive function of tumor-educated human monocytic myeloid-derived suppressor cells. Mol Cancer Res 19:702–716. 10.1158/1541-7786.MCR-20-062233372059 10.1158/1541-7786.MCR-20-0622
Sinning J Funk ND Soerensen-Zender I Wulfmeyer VC Liao CM Haller H Hinze C Schmidt-Ott KM Melk A Schmitt R The aging kidney is characterized by tubuloinflammaging, a phenotype associated with MHC-II gene expression Front Immunol 2023 14 1222339 10.3389/fimmu.2023.1222339 37675124
Sinning J, Funk ND, Soerensen-Zender I, Wulfmeyer VC, Liao CM, Haller H, Hinze C, Schmidt-Ott KM, Melk A, Schmitt R (2023) The aging kidney is characterized by tubuloinflammaging, a phenotype associated with MHC-II gene expression. Front Immunol 14:1222339. 10.3389/fimmu.2023.122233937675124 10.3389/fimmu.2023.1222339
Slattery K Woods E Zaiatz-Bittencourt V Marks S Chew S Conroy M Goggin C MacEochagain C Kennedy J Lucas S Finlay DK Gardiner CM TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer J Immunother Cancer 2021 9 e002044 10.1136/jitc-2020-002044 33568351
Slattery K, Woods E, Zaiatz-Bittencourt V, Marks S, Chew S, Conroy M, Goggin C, MacEochagain C, Kennedy J, Lucas S, Finlay DK, Gardiner CM (2021) TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer. J Immunother Cancer 9:e002044. 10.1136/jitc-2020-00204433568351 10.1136/jitc-2020-002044
Smith JR Pereira-Smith OM Altered gene expression during cellular aging Genome 1989 31 386 389 10.1139/g89-058 2687103
Smith JR, Pereira-Smith OM (1989) Altered gene expression during cellular aging. Genome 31:386–389. 10.1139/g89-0582687103 10.1139/g89-058
Sole-Boldo L Raddatz G Schütz S Mallm JP Rippe K Lonsdorf AS Rodriguez-Paredes M Lyko F Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming Commun Biol 2020 3 188 10.1038/s42003-020-0922-4 32327715
Sole-Boldo L, Raddatz G, Schütz S, Mallm JP, Rippe K, Lonsdorf AS, Rodriguez-Paredes M, Lyko F (2020) Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol 3:188. 10.1038/s42003-020-0922-432327715 10.1038/s42003-020-0922-4
Suda M Paul KH Minamino T Miller JD Lerman A Ellison-Hughes GM Tchkonia T Kirkland JL Senescent cells: a therapeutic target in cardiovascular diseases Cells 2023 12 1296 10.3390/cells12091296 37174697
Suda M, Paul KH, Minamino T, Miller JD, Lerman A, Ellison-Hughes GM, Tchkonia T, Kirkland JL (2023) Senescent cells: a therapeutic target in cardiovascular diseases. Cells 12:1296. 10.3390/cells1209129637174697 10.3390/cells12091296
Sun Y Coppe JP Lam EW Cellular senescence: The sought or the unwanted? Trends Mol Med 2018 24 871 885 10.1016/j.molmed.2018.08.002 30153969
Sun Y, Coppe JP, Lam EW (2018) Cellular senescence: The sought or the unwanted? Trends Mol Med 24:871–885. 10.1016/j.molmed.2018.08.00230153969 10.1016/j.molmed.2018.08.002
Tabula Muris Consortium A single-cell transcriptomic atlas characterizes ageing tissues in the mouse Nature 2020 583 590 595 10.1038/s41586-020-2496-1 32669714
Tabula Muris Consortium (2020) A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature 583:590–595. 10.1038/s41586-020-2496-132669714 10.1038/s41586-020-2496-1
Tadokoro T Yamamoto K Kuwahara I Fujisawa H Ikekita M Taniguchi A Sato T Furukawa K Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging Glycoconj J 2006 23 443 452 10.1007/s10719-006-7152-y 16897185
Tadokoro T, Yamamoto K, Kuwahara I, Fujisawa H, Ikekita M, Taniguchi A, Sato T, Furukawa K (2006) Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging. Glycoconj J 23:443–452. 10.1007/s10719-006-7152-y16897185 10.1007/s10719-006-7152-y
Takasugi M Yoshida Y Ohtani N Cellular senescence and the tumour microenvironment Mol Oncol 2022 16 3333 3351 10.1002/1878-0261.13268 35674109
Takasugi M, Yoshida Y, Ohtani N (2022) Cellular senescence and the tumour microenvironment. Mol Oncol 16:3333–3351. 10.1002/1878-0261.1326835674109 10.1002/1878-0261.13268
Tan J Xue Q Hu X Yang J Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis J Transl Med 2024 22 95 10.1186/s12967-024-04884-7 38263193
Tan J, Xue Q, Hu X, Yang J (2024) Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis. J Transl Med 22:95. 10.1186/s12967-024-04884-738263193 10.1186/s12967-024-04884-7
Tang Q Chen Y Li X Long S Shi Y Yu Y Wu W Han L Wang S The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers Front Immunol 2022 13 964442 10.3389/fimmu.2022.964442 36177034
Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, Wu W, Han L, Wang S (2022) The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol 13:964442. 10.3389/fimmu.2022.96444236177034 10.3389/fimmu.2022.964442
Tang D Kang R Zeh HJ Lotze MT The multifunctional protein HMGB1: 50 years of discovery Nat Rev Immunol 2023 23 824 841 10.1038/s41577-023-00894-6 37322174
Tang D, Kang R, Zeh HJ, Lotze MT (2023) The multifunctional protein HMGB1: 50 years of discovery. Nat Rev Immunol 23:824–841. 10.1038/s41577-023-00894-637322174 10.1038/s41577-023-00894-6
Tarallo D Martinez J Leyva A Monaco A Perroni C Tassano M Gambini JP Cappetta M Duran R Moreno M Quijano C Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy Sci Rep 2024 14 909 10.1038/s41598-024-51427-7 38195762
Tarallo D, Martinez J, Leyva A, Monaco A, Perroni C, Tassano M, Gambini JP, Cappetta M, Duran R, Moreno M, Quijano C (2024) Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy. Sci Rep 14:909. 10.1038/s41598-024-51427-738195762 10.1038/s41598-024-51427-7
Thomas DA Massague J TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance Cancer Cell 2005 8 369 380 10.1016/j.ccr.2005.10.012 16286245
Thomas DA, Massague J (2005) TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8:369–380. 10.1016/j.ccr.2005.10.01216286245 10.1016/j.ccr.2005.10.012
Tominaga K Suzuki HI TGF-β signaling in cellular senescence and aging-related pathology Int J Mol Sci 2019 20 5002 10.3390/ijms20205002 31658594
Tominaga K, Suzuki HI (2019) TGF-β signaling in cellular senescence and aging-related pathology. Int J Mol Sci 20:5002. 10.3390/ijms2020500231658594 10.3390/ijms20205002
Toor SM Sasidharan Nair V Decock J Elkord E Immune checkpoints in the tumor microenvironment Semin Cancer Biol 2020 65 1 12 10.1016/j.semcancer.2019.06.021 31265893
Toor SM, Sasidharan Nair V, Decock J, Elkord E (2020) Immune checkpoints in the tumor microenvironment. Semin Cancer Biol 65:1–12. 10.1016/j.semcancer.2019.06.02131265893 10.1016/j.semcancer.2019.06.021
Tribulatti MV Carabelli J Prato CA Campetella O Galectin-8 in the onset of the immune response and inflammation Glycobiology 2020 30 134 142 10.1093/glycob/cwz077 31529033
Tribulatti MV, Carabelli J, Prato CA, Campetella O (2020) Galectin-8 in the onset of the immune response and inflammation. Glycobiology 30:134–142. 10.1093/glycob/cwz07731529033 10.1093/glycob/cwz077
Trzonkowski P Szmit E Mysliwska J Mysliwski A CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence Clin Immunol 2006 119 307 316 10.1016/j.clim.2006.02.002 16545982
Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A (2006) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 119:307–316. 10.1016/j.clim.2006.02.00216545982 10.1016/j.clim.2006.02.002
Tsou PS Shi B Varga J Role of cellular senescence in the pathogenesis of systemic sclerosis Curr Opin Rheumatol 2022 34 343 350 10.1097/BOR.0000000000000898 35979691
Tsou PS, Shi B, Varga J (2022) Role of cellular senescence in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 34:343–350. 10.1097/BOR.000000000000089835979691 10.1097/BOR.0000000000000898
van de Wall S Santegoets KCM van Houtum EJH Büll C Adema GJ Sialoglycans and siglecs can shape the tumor immune microenvironment Trends Immunol 2020 41 274 285 10.1016/j.it.2020.02.001 32139317
van de Wall S, Santegoets KCM, van Houtum EJH, Büll C, Adema GJ (2020) Sialoglycans and siglecs can shape the tumor immune microenvironment. Trends Immunol 41:274–285. 10.1016/j.it.2020.02.00132139317 10.1016/j.it.2020.02.001
van Eden W Jansen MAA Ludwig I van Kooten P van der Zee R Broere F The enigma of heat shock proteins in immune tolerance Front Immunol 2017 8 1599 10.3389/fimmu.2017.01599 29209330
van Eden W, Jansen MAA, Ludwig I, van Kooten P, van der Zee R, Broere F (2017) The enigma of heat shock proteins in immune tolerance. Front Immunol 8:1599. 10.3389/fimmu.2017.0159929209330 10.3389/fimmu.2017.01599
van Tuyn J Jaber-Hijazi F MacKenzie D Cole JJ Mann E Pawlikowski JS Rai TS Nelson DM McBryan T Ivanov A Blyth K Wu H Milling S Adams PD Oncogene-expressing senescent melanocytes up-regulate MHC class II, a candidate melanoma suppressor function J Invest Dermatol 2017 137 2197 2207 10.1016/j.jid.2017.05.030 28647344
van Tuyn J, Jaber-Hijazi F, MacKenzie D, Cole JJ, Mann E, Pawlikowski JS, Rai TS, Nelson DM, McBryan T, Ivanov A, Blyth K, Wu H, Milling S, Adams PD (2017) Oncogene-expressing senescent melanocytes up-regulate MHC class II, a candidate melanoma suppressor function. J Invest Dermatol 137:2197–2207. 10.1016/j.jid.2017.05.03028647344 10.1016/j.jid.2017.05.030
Varga J Rosenbloom J Jimenez SA Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts Biochem J 1987 247 597 604 10.1042/bj2470597 3501287
Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597–604. 10.1042/bj24705973501287 10.1042/bj2470597
Vesely MD Zhang T Chen L Resistance mechanisms to anti-PD cancer immunotherapy Annu Rev Immunol 2022 40 45 74 10.1146/annurev-immunol-070621-030155 35471840
Vesely MD, Zhang T, Chen L (2022) Resistance mechanisms to anti-PD cancer immunotherapy. Annu Rev Immunol 40:45–74. 10.1146/annurev-immunol-070621-03015535471840 10.1146/annurev-immunol-070621-030155
Viel S Marcais A Guimaraes FS Loftus R Rabilloud J Grau M Degouve S Djebali S Sanlaville A Charrier E Bienvenu J Marie JC Caux C Marvel J Town L Huntington ND Bartholin L Finlay D Smyth MJ Walzer T TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway Sci Signal 2016 9 415 ra19 10.1126/scisignal.aad1884 26884601
Viel S, Marcais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E, Bienvenu J, Marie JC, Caux C, Marvel J, Town L, Huntington ND, Bartholin L, Finlay D, Smyth MJ, Walzer T (2016) TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal 9(415):ra19. 10.1126/scisignal.aad188426884601 10.1126/scisignal.aad1884
Wang D DuBois RN Immunosuppression associated with chronic inflammation in the tumor microenvironment Carcinogenesis 2015 36 1085 1093 10.1093/carcin/bgv123 26354776
Wang D, DuBois RN (2015) Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 36:1085–1093. 10.1093/carcin/bgv12326354776 10.1093/carcin/bgv123
Wang C Jurk D Maddick M Nelson G Martin-Ruiz C von Zglinicki T DNA damage response and cellular senescence in tissues of aging mice Aging Cell 2009 8 311 323 10.1111/j.1474-9726.2009.00481.x 19627270
Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, von Zglinicki T (2009) DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8:311–323. 10.1111/j.1474-9726.2009.00481.x19627270 10.1111/j.1474-9726.2009.00481.x
Wang X Guo Z Ding Z Khaidakov M Lin J Xu Z Sharma SG Jiwani S Mehta JL Endothelin-1 upregulation mediates aging-related cardiac fibrosis J Mol Cell Cardiol 2015 80 101 109 10.1016/j.yjmcc.2015.01.001 25584774
Wang X, Guo Z, Ding Z, Khaidakov M, Lin J, Xu Z, Sharma SG, Jiwani S, Mehta JL (2015) Endothelin-1 upregulation mediates aging-related cardiac fibrosis. J Mol Cell Cardiol 80:101–109. 10.1016/j.yjmcc.2015.01.00125584774 10.1016/j.yjmcc.2015.01.001
Wang TW Johmura Y Suzuki N Omori S Migita T Yamaguchi K Hatakeyama S Yamazaki S Shimizu E Imoto S Furukawa Y Yoshimura A Nakanishi M Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes Nature 2022 611 358 364 10.1038/s41586-022-05388-4 36323784
Wang TW, Johmura Y, Suzuki N, Omori S, Migita T, Yamaguchi K, Hatakeyama S, Yamazaki S, Shimizu E, Imoto S, Furukawa Y, Yoshimura A, Nakanishi M (2022a) Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature 611:358–364. 10.1038/s41586-022-05388-436323784 10.1038/s41586-022-05388-4
Wang X Xiong H Ning Z Implications of NKG2A in immunity and immune-mediated diseases Front Immunol 2022 13 960852 10.3389/fimmu.2022.960852 36032104
Wang X, Xiong H, Ning Z (2022b) Implications of NKG2A in immunity and immune-mediated diseases. Front Immunol 13:960852. 10.3389/fimmu.2022.96085236032104 10.3389/fimmu.2022.960852
Wang B Han J Elisseeff JH Demaria M The senescence-associated secretory phenotype and its physiological and pathological implications Nat Rev Mol Cell Biol 2024 10.1038/s41580-024-00727-x 39169166
Wang B, Han J, Elisseeff JH, Demaria M (2024a) The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 10.1038/s41580-024-00727-x39169166 10.1038/s41580-024-00727-x
Wang Y Sun Y Deng S Liu J Yu J Chi H Han X Zhang Y Shi J Wang Y Quan Y Li H Xu J Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors Cell Rep Med 2024 5 101374 10.1016/j.xcrm.2023.101374 38232701
Wang Y, Sun Y, Deng S, Liu J, Yu J, Chi H, Han X, Zhang Y, Shi J, Wang Y, Quan Y, Li H, Xu J (2024b) Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors. Cell Rep Med 5:101374. 10.1016/j.xcrm.2023.10137438232701 10.1016/j.xcrm.2023.101374
Wei X Luo D Yan Y Yu H Sun L Wang C Song F Ge H Qian H Li X Tang X Liu P Kojic acid inhibits senescence of human corneal endothelial cells via NF-κB and p21 signaling pathways Exp Eye Res 2019 180 174 183 10.1016/j.exer.2018.12.020 30597146
Wei X, Luo D, Yan Y, Yu H, Sun L, Wang C, Song F, Ge H, Qian H, Li X, Tang X, Liu P (2019) Kojic acid inhibits senescence of human corneal endothelial cells via NF-κB and p21 signaling pathways. Exp Eye Res 180:174–183. 10.1016/j.exer.2018.12.02030597146 10.1016/j.exer.2018.12.020
Wei Y Liang M Xiong L Su N Gao X Jiang Z PD-L1 induces macrophage polarization toward the M2 phenotype via Erk/Akt/mTOR Exp Cell Res 2021 402 112575 10.1016/j.yexcr.2021.112575 33771483
Wei Y, Liang M, Xiong L, Su N, Gao X, Jiang Z (2021) PD-L1 induces macrophage polarization toward the M2 phenotype via Erk/Akt/mTOR. Exp Cell Res 402:112575. 10.1016/j.yexcr.2021.11257533771483 10.1016/j.yexcr.2021.112575
Weyand CM Berry GJ Goronzy JJ The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease J Leukoc Biol 2018 103 565 575 10.1189/jlb.3MA0717-283 28848042
Weyand CM, Berry GJ, Goronzy JJ (2018) The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 103:565–575. 10.1189/jlb.3MA0717-28328848042 10.1189/jlb.3MA0717-283
Wicher SA Roos BB Teske JJ Fang YH Pabelick C Prakash YS Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle PLoS ONE 2021 16 e0254710 10.1371/journal.pone.0254710 34324543
Wicher SA, Roos BB, Teske JJ, Fang YH, Pabelick C, Prakash YS (2021) Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle. PLoS ONE 16:e0254710. 10.1371/journal.pone.025471034324543 10.1371/journal.pone.0254710
Wolf Y Anderson AC Kuchroo VK TIM3 comes of age as an inhibitory receptor Nat Rev Immunol 2020 20 173 185 10.1038/s41577-019-0224-6 31676858
Wolf Y, Anderson AC, Kuchroo VK (2020) TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol 20:173–185. 10.1038/s41577-019-0224-631676858 10.1038/s41577-019-0224-6
Wu CM Zheng L Wang Q Hu YW The emerging role of cell senescence in atherosclerosis Clin Chem Lab Med 2020 59 27 38 10.1515/cclm-2020-0601 32692694
Wu CM, Zheng L, Wang Q, Hu YW (2020) The emerging role of cell senescence in atherosclerosis. Clin Chem Lab Med 59:27–38. 10.1515/cclm-2020-060132692694 10.1515/cclm-2020-0601
Wykes MN Lewin SR Immune checkpoint blockade in infectious diseases Nat Rev Immunol 2018 18 91 104 10.1038/nri.2017.112 28990586
Wykes MN, Lewin SR (2018) Immune checkpoint blockade in infectious diseases. Nat Rev Immunol 18:91–104. 10.1038/nri.2017.11228990586 10.1038/nri.2017.112
Xiang Z Yin X Wei L Peng M Zhu Q Lu X Guo J Zhang J Li X Zou Y LILRB4 checkpoint for immunotherapy: Structure, mechanism and disease targets Biomolecules 2024 14 187 10.3390/biom14020187 38397424
Xiang Z, Yin X, Wei L, Peng M, Zhu Q, Lu X, Guo J, Zhang J, Li X, Zou Y (2024) LILRB4 checkpoint for immunotherapy: Structure, mechanism and disease targets. Biomolecules 14:187. 10.3390/biom1402018738397424 10.3390/biom14020187
Xu J Zhou L Liu Y Cellular senescence in kidney fibrosis: Pathologic significance and therapeutic strategies Front Pharmacol 2020 11 601325 10.3389/fphar.2020.601325 33362554
Xu J, Zhou L, Liu Y (2020) Cellular senescence in kidney fibrosis: Pathologic significance and therapeutic strategies. Front Pharmacol 11:601325. 10.3389/fphar.2020.60132533362554 10.3389/fphar.2020.601325
Xu X Masubuchi T Cai Q Zhao Y Hui E Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors Elife 2021 10 e74276 10.7554/eLife.74276 34734802
Xu X, Masubuchi T, Cai Q, Zhao Y, Hui E (2021) Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors. Elife 10:e74276. 10.7554/eLife.7427634734802 10.7554/eLife.74276
Xu P Wang M Song WM Wang Q Yuan GC Sudmant PH Zare H Tu Z Orr ME Zhang B The landscape of human tissue and cell type specific expression and co-regulation of senescence genes Mol Neurodegener 2022 17 5 10.1186/s13024-021-00507-7 35000600
Xu P, Wang M, Song WM, Wang Q, Yuan GC, Sudmant PH, Zare H, Tu Z, Orr ME, Zhang B (2022) The landscape of human tissue and cell type specific expression and co-regulation of senescence genes. Mol Neurodegener 17:5. 10.1186/s13024-021-00507-735000600 10.1186/s13024-021-00507-7
Yanai H Fraifeld VE The role of cellular senescence in aging through the prism of Koch-like criteria Ageing Res Rev 2018 41 18 33 10.1016/j.arr.2017.10.004 29106993
Yanai H, Fraifeld VE (2018) The role of cellular senescence in aging through the prism of Koch-like criteria. Ageing Res Rev 41:18–33. 10.1016/j.arr.2017.10.00429106993 10.1016/j.arr.2017.10.004
Yang R Sun L Li CF Wang YH Yao J Li H Yan M Chang WC Hsu JM Cha JH Hsu JL Chou CW Sun X Deng Y Chou CK Yu D Hung MC Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy Nat Commun 2021 12 832 10.1038/s41467-021-21099-2 33547304
Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, Hsu JL, Chou CW, Sun X, Deng Y, Chou CK, Yu D, Hung MC (2021) Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun 12:832. 10.1038/s41467-021-21099-233547304 10.1038/s41467-021-21099-2
Yi Z Ren L Wei Y Chen S Zhao J Zhu J Wu J Generation of a p21 reporter mouse and its use to identify and eliminate p21high cells in vivo Int J Mol Sci 2023 24 5565 10.3390/ijms24065565 36982640
Yi Z, Ren L, Wei Y, Chen S, Zhao J, Zhu J, Wu J (2023) Generation of a p21 reporter mouse and its use to identify and eliminate p21high cells in vivo. Int J Mol Sci 24:5565. 10.3390/ijms2406556536982640 10.3390/ijms24065565
Yin Z Yu M Ma T Zhang C Huang S Karimzadeh MR Momtazi-Borojeni AA Chen S Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1 J Immunother Cancer 2021 9 e001698 10.1136/jitc-2020-001698 33472857
Yin Z, Yu M, Ma T, Zhang C, Huang S, Karimzadeh MR, Momtazi-Borojeni AA, Chen S (2021) Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. J Immunother Cancer 9:e001698. 10.1136/jitc-2020-00169833472857 10.1136/jitc-2020-001698
Yousefzadeh MJ Zhao J Bukata C Wade EA McGowan SJ Angelini LA Bank MP Gurkar AU McGuckian CA Calubag MF Kato JI Burd CE Robbins PD Niedernhofer LJ Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice Aging Cell 2020 19 e13094 10.1111/acel.13094 31981461
Yousefzadeh MJ, Zhao J, Bukata C, Wade EA, McGowan SJ, Angelini LA, Bank MP, Gurkar AU, McGuckian CA, Calubag MF, Kato JI, Burd CE, Robbins PD, Niedernhofer LJ (2020) Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell 19:e13094. 10.1111/acel.1309431981461 10.1111/acel.13094
Yu H Sun L Cui J Li Y Yan Y Wei X Wang C Song F Jiang W Liu Y Ge H Qian H Li X Tang X Liu P Three kinds of corneal host cells contribute differently to corneal neovascularization EBioMedicine 2019 44 542 553 10.1016/j.ebiom.2019.05.026 31126890
Yu H, Sun L, Cui J, Li Y, Yan Y, Wei X, Wang C, Song F, Jiang W, Liu Y, Ge H, Qian H, Li X, Tang X, Liu P (2019) Three kinds of corneal host cells contribute differently to corneal neovascularization. EBioMedicine 44:542–553. 10.1016/j.ebiom.2019.05.02631126890 10.1016/j.ebiom.2019.05.026
Zhang Q Vignali DA Co-stimulatory and co-inhibitory pathways in autoimmunity Immunity 2016 44 1034 1051 10.1016/j.immuni.2016.04.017 27192568
Zhang Q, Vignali DA (2016) Co-stimulatory and co-inhibitory pathways in autoimmunity. Immunity 44:1034–1051. 10.1016/j.immuni.2016.04.01727192568 10.1016/j.immuni.2016.04.017
Zhang Y Cai P Li L Shi L Chang P Liang T Yang Q Liu Y Wang L Hu L Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients Int Immunopharmacol 2017 43 210 218 10.1016/j.intimp.2016.12.024 28038383
Zhang Y, Cai P, Li L, Shi L, Chang P, Liang T, Yang Q, Liu Y, Wang L, Hu L (2017) Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients. Int Immunopharmacol 43:210–218. 10.1016/j.intimp.2016.12.02428038383 10.1016/j.intimp.2016.12.024
Zhang Y Zhu S Du Y Xu F Sun W Xu Z Wang X Qian P Zhang Q Feng J Xu Y RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion J Exp Clin Cancer Res 2022 41 66 10.1186/s13046-022-02243-2 35177112
Zhang Y, Zhu S, Du Y, Xu F, Sun W, Xu Z, Wang X, Qian P, Zhang Q, Feng J, Xu Y (2022) RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion. J Exp Clin Cancer Res 41:66. 10.1186/s13046-022-02243-235177112 10.1186/s13046-022-02243-2
Zhang L Pitcher LE Prahalad V Niedernhofer LJ Robbins PD Targeting cellular senescence with senotherapeutics: senolytics and senomorphics FEBS J 2023 290 1362 1383 10.1111/febs.16350 35015337
Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD (2023) Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J 290:1362–1383. 10.1111/febs.1635035015337 10.1111/febs.16350
Zhao Y Qu Y Hao C Yao W PD-1/PD-L1 axis in organ fibrosis Front Immunol 2023 14 1145682 10.3389/fimmu.2023.1145682 37275876
Zhao Y, Qu Y, Hao C, Yao W (2023) PD-1/PD-L1 axis in organ fibrosis. Front Immunol 14:1145682. 10.3389/fimmu.2023.114568237275876 10.3389/fimmu.2023.1145682
Zheng M Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity J Immunother Cancer 2023 11 e006462 10.1136/jitc-2022-006462 36889809
Zheng M (2023) Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity. J Immunother Cancer 11:e006462. 10.1136/jitc-2022-00646236889809 10.1136/jitc-2022-006462
Zhou H Li N Yuan Y Jin YG Wu Q Yan L Bian ZY Deng W Shen DF Li H Tang QZ Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway J Mol Med (berl) 2020 98 691 705 10.1007/s00109-020-01896-w 32280997
Zhou H, Li N, Yuan Y, Jin YG, Wu Q, Yan L, Bian ZY, Deng W, Shen DF, Li H, Tang QZ (2020) Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway. J Mol Med (berl) 98:691–705. 10.1007/s00109-020-01896-w32280997 10.1007/s00109-020-01896-w
Zou Z Long X Zhao Q Zheng Y Song M Ma S Jing Y Wang S He Y Esteban CR Yu N Huang J Chan P Chen T Izpisua Belmonte JC Zhang W Qu J Liu GH A single-cell transcriptomic atlas of human skin aging Dev Cell 2021 56 383 397.e8 10.1016/j.devcel.2020.11.002 33238152
Zou Z, Long X, Zhao Q, Zheng Y, Song M, Ma S, Jing Y, Wang S, He Y, Esteban CR, Yu N, Huang J, Chan P, Chen T, Izpisua Belmonte JC, Zhang W, Qu J, Liu GH (2021) A single-cell transcriptomic atlas of human skin aging. Dev Cell 56:383-397.e8. 10.1016/j.devcel.2020.11.00233238152 10.1016/j.devcel.2020.11.002
